Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | P4 - Poster Session 4

Monday 04/15/24
11:45 AM - 12:45 PM MDT Add To Calendar
Colorado Convention Center | Exhibit Hall B-E
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Poster Session
General Neurology, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Neurocritical Care, Neurohospitalist, Neuromuscular and Clinical Neurophysiology (EMG), Practice, Policy, and Ethics
View the latest research on a variety of topics. Posters are available in-person or online.
0.00 CME credit
Patient Care & Procedural Skills, Professionalism, Practice-based Learning and Improvement, Systems-based Practice
Neurohospitalist
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Interactive

Program Materials Program Evaluations

Event Timeline
11:45 AM - 12:45 PM MDT Abstract 9-001 - Regional Brain 3R/4R RT-QuIC Seeding Reflects Patterns of AD Pathology and Correlates with Histopathological Burden of Disease
Varun Sai Rachakonda
11:45 AM - 12:45 PM MDT Abstract 9-002 - Feasibility of Using Blood-based Biomarkers to Evaluate the Effectiveness of Individualized Neurodegenerative Disease Preventive Care
Philip Edward Sisser
11:45 AM - 12:45 PM MDT Abstract 9-003 - Comparing the Development of Post-stroke Depression Based on Location of Cerebral Artery Infarcts
Varun Sai Rachakonda
11:45 AM - 12:45 PM MDT Abstract 9-004 - Clinical and Neuroanatomical Characterization of the Semantic Behavioural Variant of Frontotemporal Dementia in a Multicentre Italian Cohort
Edoardo G. Spinelli, MD
11:45 AM - 12:45 PM MDT Abstract 9-005 - Inflammatory Cytokines Profiles and Cognition Among Older Adults
Aline Thomas, PhD
11:45 AM - 12:45 PM MDT Abstract 9-006 - ANO6 Regulates Lipid Droplets in Astrocyte via Fatty Acid Uptake and Is Involved in Inflammation
Kexin Li, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 9-007 - Pathologic Changes in ELAVL3 Expression and Splicing Occur in TDP43 and Non-TDP43 Proteinopathies
Isabel Costantino
11:45 AM - 12:45 PM MDT Abstract 9-008 - Plasma GFAP in the Visual and Language Variants of Alzheimer’s Disease
Irene Sintini, PhD
11:45 AM - 12:45 PM MDT Abstract 9-009 - LesionBank.org: An Open Source Platform for Brain Lesion Case Reports
Joseph Isaac Turner
11:45 AM - 12:45 PM MDT Abstract 9-010 - A Case of Adult-onset MELAS as a Rapidly Progressive Dementia: Variant of Unknown Significance and the Importance of Neuropathologic Confirmation
Molly Kate Wiggins, MD
11:45 AM - 12:45 PM MDT Abstract 9-011 - Pattern of Brain Structural Alternations Related to Deep Medullary Veins Injury
Zi-Yue Liu
11:45 AM - 12:45 PM MDT Abstract 9-012 - Associations of Liver Dysfunction with Incident Dementia, Cognition, and Brain Structure: A Prospective Cohort Study of 431,699 Adults
Ya-Nan Ou
11:45 AM - 12:45 PM MDT Abstract 9-013 - Association of a Multiplex Immune Marker Panel with Incident Cognitive Impairment and Dementia: The Northern Manhattan Study
Mohammad Abdurrehman Sheikh, MBBS
11:45 AM - 12:45 PM MDT Abstract 9-014 - Comorbid Pathology in Clinical Trial Participants: Autopsy Findings and Clinical Features
Elif Pinar Coskun, MD
11:45 AM - 12:45 PM MDT Abstract 9-016 - Characterizing the Effects of Progranulin Reduction on Tau Pathology and Phenotypes in a Mouse Model of Tauopathy
Sanaea Zubin Bhagwagar
11:45 AM - 12:45 PM MDT Abstract 9-017 - Characterizing Ligands that have Immunomodulatory Potential at the Choroid Plexus in Neurodegenerative Disease
Bhavya Bakshi
11:45 AM - 12:45 PM MDT Abstract 9-018 - Neuronal Intranuclear Inclusion Disease in New Zealand: A Novel Finding and Potential Polynesian Founder Effect
Tony Zhang, MBChB
11:45 AM - 12:45 PM MDT Abstract 15-001 - Impact of a Non-mydriatic Ocular Fundus Camera at a Quaternary Care Emergency Department
Valerie Biousse, MD
11:45 AM - 12:45 PM MDT Abstract 15-002 - Characteristics, Complications, and Outcomes of Critical Illness in Patients with Parkinson’s Disease.
Ori Lieberman, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 15-003 - Lumbar Puncture, Pneumocephalus, and a Transient Cranial Nerve Palsy: A Case Report
Anas Idris, MD
11:45 AM - 12:45 PM MDT Abstract 15-004 - Quality Assessment/Quality Improvement Measures for the Neurological Care of the Post Cardiac Arrest Patient at VA Pittsburgh Health Care System
Maria E. Baldwin, MD
11:45 AM - 12:45 PM MDT Abstract 3-001 - Constipation in Early-onset Parkinson’s Disease: Frequency, Time of Onset and Association with Mortality
Capucine Piat
11:45 AM - 12:45 PM MDT Abstract 3-002 - Longitudinal Patterns of Depression and Anxiety in Parkinson Disease
Omolara Lawal, MD
11:45 AM - 12:45 PM MDT Abstract 3-003 - Association of Severe Hyposmia and Frontal Lobe Dysfunction in Patients with Parkinson’s Disease
Motohiro Okumura, MD
11:45 AM - 12:45 PM MDT Abstract 3-004 - Melanoma Risk and Timing of Parkinson Disease Diagnosis
James Searson
11:45 AM - 12:45 PM MDT Abstract 3-005 - Parkinson's Disease and Loneliness: An Initial Exploration
Tila Warner-Rosen
11:45 AM - 12:45 PM MDT Abstract 3-006 - Interim Analysis of Istradefylline Effects on Tremor in Parkinson's Disease Patients—Promising Benefits on Tremor Control
Irma Zhang
11:45 AM - 12:45 PM MDT Abstract 3-007 - Off-the-shelf Bioreactor Produced, iPSC-derived Neural Microtissues Containing Dopaminergic Neurons Innervate the Striatum and Normalize Behavior in a Parkinson Rat Model
Kevin Alessandri
11:45 AM - 12:45 PM MDT Abstract 3-008 - Comparing the NIH Toolbox-cognition Battery and Montreal Cognitive Assessment to Assess Cognitive Impairment in Patients with Parkinson Disease
Aashish Batheja
11:45 AM - 12:45 PM MDT Abstract 3-009 - Initiation of Apomorphine Hydrochloride Injection (Apokyn) in the Absence of an Antiemetic in People with Parkinson’s Disease
Cindy Marie Happel, RN
11:45 AM - 12:45 PM MDT Abstract 3-010 - Exploring Knowledgeable Informant Reporting on the Earliest Changes of Parkinson’s Disease
Caroline M. Tanner, MD, PhD, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-011 - Acceptability and Efficacy of a Novel Parkinson’s Care Partner Training Program
Jori Fleisher, MD, MSCE, FAAN
11:45 AM - 12:45 PM MDT Abstract 3-012 - Sensitivity and Specificity of the Whistle-smile Reflex in Patients with Parkinson’s Disease
Mateus Damiani Monteiro, MD
11:45 AM - 12:45 PM MDT Abstract 3-013 - Comparison of Three Oral Amantadine Formulations: A Population Pharmacokinetic Study
Zhao Wang, PhD
11:45 AM - 12:45 PM MDT Abstract 3-014 - Modern Approaches to the Diagnosis of Patients with Parkinson’s Disease
Nargiza Mansurova, PhD
11:45 AM - 12:45 PM MDT Abstract 3-015 - The Relationship Between Psychosis and Cognitive Function in Parkinson Disease
Nicole Bonsavage, MD
11:45 AM - 12:45 PM MDT Abstract 3-016 - Aerobic Fitness Is Associated with Better Cognitive and Motor Function in Mild-moderate Parkinson’s Disease
Ergun Y. Uc, MD
11:45 AM - 12:45 PM MDT Abstract 3-017 - Patient Characteristics and Real-world Use of Botulinum Toxins for Treatment of Chronic Sialorrhea
Michael Hast
11:45 AM - 12:45 PM MDT Abstract 3-018 - Cognitive Predictors of Quality of Life in Parkinson’s Disease: A Three-year Longitudinal Study
Katharine Ann Henry, MD
11:45 AM - 12:45 PM MDT Abstract 3-019 - Optimizing a Patient’s Oral CD-LD Dosing Regimen Is Critical for Improving Efficacy in Parkinson’s Disease
Ghazal Banisadr, PhD
11:45 AM - 12:45 PM MDT Abstract 3-020 - Assessing Feasibility of Phone Video Data in Diagnosing Parkinsonism
Zahin Ahmed
11:45 AM - 12:45 PM MDT Abstract 12-001 - Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of Chronic Migraine: A Retrospective Chart Review
Rita Singh, PharmD
11:45 AM - 12:45 PM MDT Abstract 12-002 - Fremanezumab Effectiveness and Tolerability in Clinical Routine: Interim Real-world Data of the Observational FINESSE Study
Mario Ortega, PhD
11:45 AM - 12:45 PM MDT Abstract 12-004 - Utilization of Health Care Resources and Sick Leave in a Large Cohort of Migraine Patients: A Real-world Data Analysis
Matanya Tirosh
11:45 AM - 12:45 PM MDT Abstract 12-005 - Impact of Psychiatric Conditions on the Real-world Effectiveness of Eptinezumab Treatment in Patients with Chronic Migraine
Charles E. Argoff, MD
11:45 AM - 12:45 PM MDT Abstract 12-006 - 6-month Real-world Effectiveness of Fremanezumab in Patients with Migraine who Switched from Another mAb Targeting the CGRP Pathway (Subgroup Analysis from FINESSE)
Verena Ramirez Campos, MD
11:45 AM - 12:45 PM MDT Abstract 12-007 - Comorbidity Rates in a Large Cohort of Patients with Migraine: A Real-world Data Analysis
Matanya Tirosh
11:45 AM - 12:45 PM MDT Abstract 12-008 - Real-world Switching Rates of Atogepant Are Lower than CGRP Monoclonal Antibodies (mAbs) in Patients with Migraine Using Claims Database
Karen Carr, PhD
11:45 AM - 12:45 PM MDT Abstract 12-009 - Characteristics of and Treatment Patterns Among Pediatric Patients with Post-traumatic Headache in a Pediatric Neurology Setting
Caroline Gentile Kruse, MD
11:45 AM - 12:45 PM MDT Abstract 12-010 - Education on Preventative Migraine Therapy Impacts Real-world Treatment Selection
Thomas Finnegan, Jr., PhD
11:45 AM - 12:45 PM MDT Abstract 6-001 - Attention to Sex as a Biological Variable in Phase III Neurological Trials Before and After the 2017 NIH Amendment: a Systematic Review in MS
Ayushi Dinesh Balan
11:45 AM - 12:45 PM MDT Abstract 6-002 - Efficacy and Safety of Two Therapeutic Strategies in a Multiple Sclerosis Population of Afro-Caribbean Descent
Hugo Chaumont, MD
11:45 AM - 12:45 PM MDT Abstract 6-003 - Ocrelizumab for Pediatric Relapsing Multiple Sclerosis
Malak AlMojel, MD
11:45 AM - 12:45 PM MDT Abstract 6-004 - VISIBL-MS: A Bilingual Educational Tool to Increase Awareness of Early Multiple Sclerosis in Diverse Populations
Shivam Patel
11:45 AM - 12:45 PM MDT Abstract 6-005 - Real-world Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates
Sophia Woodson
11:45 AM - 12:45 PM MDT Abstract 6-006 - Clinical Characteristics of Multiple Sclerosis in an Asian American Population
Manali Divyesh Shah, MD
11:45 AM - 12:45 PM MDT Abstract 6-007 - Performance of the 2023 Adult Criteria for the Radiologically Isolated Syndrome in Children and Comparison to the 2009 Criteria
Naila Makhani, MD
11:45 AM - 12:45 PM MDT Abstract 6-008 - Choroid Plexus Volume Disparities in Multiple Sclerosis Patients: A Comparative Analysis Between African American and Caucasian Cohorts
Carla E. Santiago-Martinez
11:45 AM - 12:45 PM MDT Abstract 6-009 - Pediatric-onset Multiple Sclerosis in Kuwait
Malak AlMojel, MD
11:45 AM - 12:45 PM MDT Abstract 6-010 - The Relationship Between Socioeconomic Status and Disability in MS Is Linked to Diet
Ilana B. Katz Sand, MD
11:45 AM - 12:45 PM MDT Abstract 6-011 - Novel Observations in the Management of Relapsing Non-syndromic Pediatric Tumefactive Demyelinating Lesions
Nikita Shukla, MD
11:45 AM - 12:45 PM MDT Abstract 6-012 - Healthcare Utilization Barriers in Multiple Sclerosis Patients Transitioning from Adolescent to Adult Care: A Multi-institutional Database Analysis in the United States
Trieste Francis
11:45 AM - 12:45 PM MDT Abstract 6-013 - Assessing Safety of High-efficacy Multiple Sclerosis Therapies in Elderly Patients
Juan Ignacio Kenny, MD
11:45 AM - 12:45 PM MDT Abstract 6-014 - Risk Factors for Peripartum Mood Disorders in Women with MS: A Prospective Study
Madeleine Rose
11:45 AM - 12:45 PM MDT Abstract 6-015 - Safety of Discontinuing Disease-modifying Therapy in Aging MS Patients: A Single-center Study
Cori Polonski, MD
11:45 AM - 12:45 PM MDT Abstract 6-016 - Multiple Sclerosis in a Patient with Friedreich's Ataxia
Yang Yu, MD
11:45 AM - 12:45 PM MDT Abstract 6-017 - Effectiveness and Safety of High-efficacy Disease-modifying Therapy in Pediatric Multiple Sclerosis: A Retrospective Analysis at a Single Center
Rachel Walsh, MD
11:45 AM - 12:45 PM MDT Abstract 6-018 - Ethnic Disparities in the Incidence and Prevalence of Multiple Sclerosis
Gagana Kethaka Mallawa Arac Mallawaarachchi
11:45 AM - 12:45 PM MDT Abstract 7-001 - Medical Student Narrative Evaluations of Resident Teachers: A Qualitative Study
Harry William Sutherland, MD
11:45 AM - 12:45 PM MDT Abstract 7-002 - Simulation-based Training for Neurology and Neurosurgery Residents in ICU Procedures
Isha Snehal, MBBS
11:45 AM - 12:45 PM MDT Abstract 7-003 - A Qualitative Analysis of Communication-focused Feedback Provided to Child Neurology Residents During an Objective Structured Clinical Exam (OSCE)
Dara V. Albert, DO, FAAN
11:45 AM - 12:45 PM MDT Abstract 7-004 - Implementation of an Objective Structured Clinical Examination (OSCE) to Improve the Delivery of a Functional Neurological Disorder (FND) Diagnosis
Alana Jessica Kosches
11:45 AM - 12:45 PM MDT Abstract 7-005 - Qualitative Evaluation of an Interactive Art Intervention to Improve Resident Comfort with Working with Adults with Intellectual and Developmental Disabilities (IDD)
Jessica Sanders, MD
11:45 AM - 12:45 PM MDT Abstract 7-006 - Integrating Quality Improvement Curriculum and Group Projects: A Neurology Resident-Guided Initiative
Austin Michael Saline, MD
11:45 AM - 12:45 PM MDT Abstract 7-007 - Effects of Implementation of a Night Float System in a Neurology Residency Program
Samantha McMahon, DO
11:45 AM - 12:45 PM MDT Abstract 7-008 - An Analysis of ACGME Resident Well-being Survey data and Its Correlation to a Resident-administered Well-being Survey
Lauren Bojarski, DO
11:45 AM - 12:45 PM MDT Abstract 1-001 - People with Epilepsy (PWE) and Attention Deficit Hyperactive Disorder (ADHD)/Attention Deficit Disorder (ADD)
Syed Muhammad Owais
11:45 AM - 12:45 PM MDT Abstract 1-002 - Increased Incidence of Comorbidities in Patients with Uncontrolled Epilepsy
Emily Klatte, MD
11:45 AM - 12:45 PM MDT Abstract 1-003 - Depression in Older Adults with Epilepsy: A Cross-sectional Study Examining Prevalence, Risk Factors, and Socio-demographic Correlates in the Detroit Metropolitan Geriatric Population
Maryam Jamil Syed, MBBS
11:45 AM - 12:45 PM MDT Abstract 1-004 - Clinical Importance of Anxiety Screening in Older Adults with Epilepsy
Jeongyeon Hwang, MD
11:45 AM - 12:45 PM MDT Abstract 1-005 - Factors Associated with Risk for Depression in People with Epilepsy
Kaylie Kaneshiro
11:45 AM - 12:45 PM MDT Abstract 1-006 - High Rates of Pregnancy Complications in Patients with Functional Seizures
Christina Rose Kyrtsos Catherine, MD
11:45 AM - 12:45 PM MDT Abstract 1-007 - Emergent C-section: Unusual Complication of Psychogenic Non-epileptic Spells
Estevao Pereira Ribeiro, MD
11:45 AM - 12:45 PM MDT Abstract 1-008 - Pregnancy Outcomes and Seizure Control in Underserved Patients with Epilepsy
Parisa Hassanzadeh, MD
11:45 AM - 12:45 PM MDT Abstract 1-009 - Differences in Delivery Type, Breastfeeding Initiation, and Length of Postpartum Hospitalization in Patients with Epilepsy within a Single Hospital System
Kelly Rios
11:45 AM - 12:45 PM MDT Abstract 1-010 - Progesterone-induced Cross-tolerance with Benzodiazepines in Some Women with Catamenial Epilepsy
Andrew G. Herzog, MD, MSc, FAAN
11:45 AM - 12:45 PM MDT Abstract 1-011 - Pregnancy Outcomes Following Exposure to Lacosamide: Prospective Data from Spontaneous and Solicited Reports
Paula Emanuela Voinescu, MD
11:45 AM - 12:45 PM MDT Abstract 1-012 - Highly Purified Cannabidiol (CBD) Use and Therapeutic Drug Monitoring in Pregnancy: A Case Report
Hrishikesh Dadhich, MD
11:45 AM - 12:45 PM MDT Abstract 1-013 - Are Recurrent Focal Seizures or Focal Status Epilepticus in Older Adults a Risk Factor for Early Mortality?
Abram Wahba, MD
11:45 AM - 12:45 PM MDT Abstract 1-014 - An Observational Study to Explore Burden of Epilepsy for Caregivers and Understand Perspectives of Health Care Providers in Argentina, China, and Taiwan
Ioannis Karakis, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 1-015 - Navigating Life after New-onset Refractory Status Epilepticus (NORSE) and Febrile-infection Related Epilepsy Syndrome (FIRES): Insights from Caregiver Interviews
Krista L. Eschbach, MD
11:45 AM - 12:45 PM MDT Abstract 1-016 - Analysis of Physician Notes to Examine the Clinical and Humanistic Burden of Patients with Dravet Syndrome and Lennox-Gastaut Syndrome in the United States
Satish C. Rao, MD,MS
11:45 AM - 12:45 PM MDT Abstract 10-001 - Eye Movement Characteristics of Congenital Myasthenic Syndromes
Ruben Jauregui, MD
11:45 AM - 12:45 PM MDT Abstract 10-002 - Fatiguing Saccades to Differentiate Ocular Motor Localization: A Pilot Study
Arens Taga, MD
11:45 AM - 12:45 PM MDT Abstract 10-003 - TeleAutoHINTS: A Virtual/Augmented Reality System for Automated Tele-neurologic Evaluation of Acute Vertigo
Haochen Wei
11:45 AM - 12:45 PM MDT Abstract 10-004 - Clinician-reported Factors Influencing Performance of Cognitive Evaluations in Primary Care
Kyra O'Brien, MD
11:45 AM - 12:45 PM MDT Abstract 10-005 - Comparing how Antiseizure Medications are Publicly Regulated by Australia and New Zealand
Daniel Paul Ashley, MPA
11:45 AM - 12:45 PM MDT Abstract 10-006 - Introduction of the Cultural Formulation Interview on the Inpatient Neurology Service
Vani Kumar
11:45 AM - 12:45 PM MDT Abstract 4-001 - In-house Diagnosis and Management of Peripheral Vertigo Patients, Where Do We Stand? An Adult Neurology Quality Improvement Study
Lobna Ahmed Mohammed Abdelwahab, MD
11:45 AM - 12:45 PM MDT Abstract 4-002 - Racial and Ethnic Disparities in the Incidence of Neuromyelitis Optica Spectrum Disorder
Angus Lee, DO
11:45 AM - 12:45 PM MDT Abstract 4-003 - Krabbe Disease Presenting As Combined Peripheral and Central Demyelinating Disease: A Case Report
Joshua Thomas Blotter, MD
11:45 AM - 12:45 PM MDT Abstract 4-004 - VHB937, a TREM2 Stabilizing and Activating Antibody Strongly Reduces Pathology After Peripheral Administration in a Broad Range of Animal Models for Neuroinflammation and Neurodegeneration
Martin Stangel, MD
11:45 AM - 12:45 PM MDT Abstract 4-005 - Adrenoleukodystrophy Masquerading as Chronic Immune Demyelinating Polyradiculoneuropathy in a Patient with HIV
Sarah Guistolisi, MD
11:45 AM - 12:45 PM MDT Abstract 4-006 - Low Vasopressin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Helena Huhmar
11:45 AM - 12:45 PM MDT Abstract 4-007 - A Decade of Deception: Wolfram Syndrome Masquerading as Multiple Sclerosis
Talha Ahmad
11:45 AM - 12:45 PM MDT Abstract 4-008 - A Combined Central and Peripheral Demyelination (CPPD) Syndrome After COVID-19 Vaccination
Lydia Kauffman, MD
11:45 AM - 12:45 PM MDT Abstract 4-009 - Prevalence and Characteristics of Patients with Both White Matter Disorders and Peripheral Neuropathy Due to Inherited Versus Acquired Causes
Malya Sahu, MD
11:45 AM - 12:45 PM MDT Abstract 4-010 - Differential Diagnosis of Leptomeningeal Enhancement in the Pediatric Population
Gabriela Alejandra Bou, MD
11:45 AM - 12:45 PM MDT Abstract 4-011 - Two to Tango: Subacute Combined Degeneration with Encephalopathy due to Deficiency of B12 and Copper
Muhammad Ismail Khalid Yousaf, MD
11:45 AM - 12:45 PM MDT Abstract 4-012 - Safety, Tolerability, and Pharmacokinetics of Single and Multiple Rising Doses of a Next Generation Prodrug Troriluzole in Healthy Subjects
Heather Sevinsky, Other
11:45 AM - 12:45 PM MDT Abstract 4-013 - Troriluzole Exhibits Favorable Hepatic Safety Profile Across a Diverse Range of Disorders
Irfan Qureshi, MD
11:45 AM - 12:45 PM MDT Abstract 4-014 - No Clinically Relevant Effects of Hepatic Impairment on the Pharmacokinetics of a Next Generation Prodrug Troriluzole
Heather Sevinsky, Other
11:45 AM - 12:45 PM MDT Abstract 13-002 - Mesiotemporal Involvement in Neurosyphilis
Joo Won Choi
11:45 AM - 12:45 PM MDT Abstract 13-003 - Neurosyphilis in Disguise
Anas Idris, MD
11:45 AM - 12:45 PM MDT Abstract 13-004 - Role of Pulse Methylprednisolone in Children with Vasculitis Due to Tubercular Meningitis
Lokesh Saini, DM
11:45 AM - 12:45 PM MDT Abstract 13-005 - Dysautonomia Secondary to Progressive Tuberculous Meningitis in an Immunocompetent Patient Despite Antimicrobial Therapy
Raissa Aoun, MD
11:45 AM - 12:45 PM MDT Abstract 13-007 - Isoniazid-induced Peripheral Neuropathy: What’s the Effect of Concomitant Type-2 Diabetes Mellitus?
Manasvi Gupta
11:45 AM - 12:45 PM MDT Abstract 13-008 - Optochiasmatic Arachnoiditis - A Devastating Complication of Tuberculous Meningitis
Shanindra Revanka De Alwis, MD, MBBS
11:45 AM - 12:45 PM MDT Abstract 13-009 - Beyond the Lungs: Tuberculosis Unleashed – A Neurological Wake-up Call
Mohammad Hani Mohammad Almomani, MD
11:45 AM - 12:45 PM MDT Abstract 5-001 - Natural History of FGFR Gliomas
Maya Viera, Other
11:45 AM - 12:45 PM MDT Abstract 5-002 - Germline Fumarate Hydratase Mutations May be Associated with High-grade Gliomas and Mimic the Methylation Profile of IDH-mutant Gliomas
Sasmit Sarangi, MBBS, MD
11:45 AM - 12:45 PM MDT Abstract 5-003 - Hypertonic Saline Solution Versus Mannitol for Brain Relaxation During Craniotomies: An Updated Meta-analysis
Artur Menegaz de Almeida
11:45 AM - 12:45 PM MDT Abstract 5-004 - Metabolomic Approach to Identification of Prognostic Biomarkers of Glioblastoma
Orwa Aboud, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-005 - Pathogenic MUYTH and Novel H3F3A Variants in Glioblastoma: A Case Report and Literature Review
Ryan Rilinger
11:45 AM - 12:45 PM MDT Abstract 5-006 - Long-term Survival in a WHO Grade 4 IDH-mutant Astrocytoma Using a Farnesyltransferase Inhibitor in Combination with Temozolomide
Catherine R. Garcia, MD
11:45 AM - 12:45 PM MDT Abstract 5-007 - Selumetinib Halts Progression of Orbital/Periorbital Plexiform Neurofibromas in Neurofibromatosis Type 1
Ruben Jauregui, MD
11:45 AM - 12:45 PM MDT Abstract 5-008 - A Neural Implant for Cytostatic Hypothermia in Swine
Justine Ker, MD
11:45 AM - 12:45 PM MDT Abstract 5-009 - Novel Fusion GNAI2::BRAF as Driver for Pilocytic Astrocytoma: A Case Report
Maria A. Minor, MD
11:45 AM - 12:45 PM MDT Abstract 5-010 - Glioblastoma Multiforme Tumor Volume and Persistence of Chimeric Antigen Receptor T Cells Following Neurosurgical Debulking
Devi Veerappan
11:45 AM - 12:45 PM MDT Abstract 5-011 - Efficacy and Safety of Stereotactic Radiosurgery Versus Whole Brain Radiotherapy for the Management of Brain Metastasis: A Systematic Review and Meta-analysis
Ahmed Said Negida, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-012 - Blood Neurofilament Light Chain Measurements in Adults with CNS Histiocytic Neoplasms
Samantha Banks, MD
11:45 AM - 12:45 PM MDT Abstract 5-013 - Disparities in Neuro-oncology: Highlighting Specific Target Areas for Improvement of Healthcare Disparities
Nara Michaelson, MD
11:45 AM - 12:45 PM MDT Abstract 5-014 - Differential Glioma Mortality and Grading in Disaggregated Asian American Subgroups: Insights from SEER 2000-2020
Shreya Sri Gunda
11:45 AM - 12:45 PM MDT Abstract 5-015 - Neuro-oncological Research Output in the Middle East: A Scoping Review
Ibraheem Mashhour Alkhawaldeh, MD
11:45 AM - 12:45 PM MDT Abstract 5-016 - Neuro-oncological Research Output in Africa: A Scoping Review
Ahmed Said Negida, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-017 - Smoking-related Genomic Alterations Are Observed in Patients with Glioma and May Contribute to Shortened Survival
Julia Michelle Landry
11:45 AM - 12:45 PM MDT Abstract 5-018 - Isolated Nervous System Histiocytic Neoplasms: Clinical Manifestations, Treatment, and Outcomes
Nabeela Nathoo, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-019 - Longitudinal Volumetric Analysis of FLAIR Hyperintensity Following Radiation Therapy (RT) in Patients with Low-grade Glioma (LGG)
Isabella Sutherland
11:45 AM - 12:45 PM MDT Abstract 5-021 - Urgent Caesarean Section Followed by Tumor Resection for Pregnancy-related Rapid Growth of WHO Grade 1 Pilocytic Astrocytoma
Diana M. Barratt, MD, MPH, FAAN
11:45 AM - 12:45 PM MDT Abstract 5-022 - Case Report of an Incidental Suprasellar Anaplastic Hemangiopericytoma
Michele Persico, MD
11:45 AM - 12:45 PM MDT Abstract 5-023 - Intravascular Lymphoma with Central Nervous System Involvement: Mayo Clinic Experience
Bryan Joseph Neth, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 5-024 - Clinical Characteristics and Treatment Approaches for H3K27-altered Diffuse Midline Glioma in Adolescents and Young Adults
Nupur Lala, MD
11:45 AM - 12:45 PM MDT Abstract 5-025 - Discrepancy in CSF Flow Cytometry Results from Lumbar Puncture and Ventricular Sampling Leading to Delay in Diagnosis Recurrent CNS Lymphoma: A Case Report
Neil Sielski, MD
11:45 AM - 12:45 PM MDT Abstract 5-026 - Evaluating Minimally Invasive Approaches to Meningioma Treatment
Varun Sai Rachakonda
11:45 AM - 12:45 PM MDT Abstract 5-027 - Lymphomatoid Granulomatosis: A Rare Lymphoproliferative Disorder on the Differential Diagnosis for Brain and Spinal Cord Lesions
Sneha Lingam
11:45 AM - 12:45 PM MDT Abstract 5-029 - Cerebral Angiosarcoma and Distance Radiation Therapy
Ariana Michelle Frontario, DO
11:45 AM - 12:45 PM MDT Abstract 5-030 - Craniopharyngioma and Severe Hypercalcemia: Metabolic Derangements from Local Invasion
Michael Edward Limia
11:45 AM - 12:45 PM MDT Abstract 5-031 - A Rare Case of Multiple Brain Metastases from Urothelial Cancer: A Case Report
Darshil Shah, MBBS
11:45 AM - 12:45 PM MDT Abstract 5-032 - A Rare Case of Primary Pineal Melanoma with Metastasis in an African American Patient
Micah Sy, MD
11:45 AM - 12:45 PM MDT Abstract 2-001 - Impact of Direct Outcome to a Comprehensive Epilepsy Center in Patients with Status Epilepticus
Julio A. Chalela, MD
11:45 AM - 12:45 PM MDT Abstract 2-002 - Patient Journey in Status Epilepticus: Understanding Treatment Pathways, Outcomes, and Health Care Burden Using Patient Level Hospital Data
Megan Barra
11:45 AM - 12:45 PM MDT Abstract 2-003 - VIGAB-STAT—A Phase IIa Feasibility Trial of Irreversible GABA-transaminase Inhibition as Adjunct Treatment of Status Epilepticus After Cardiac Arrest
Bakhtawar Ahmad, MBBS
11:45 AM - 12:45 PM MDT Abstract 2-004 - Improved Outcome Prediction in Neurocritical Care Using Multimodal Neuromonitoring
Sérgio Brasil, MD,PhD
11:45 AM - 12:45 PM MDT Abstract 2-005 - Improved Neuromonitoring for Critically Ill Patients Using Contextual Data
Samir Dhansukh Ruxmohan, DO
11:45 AM - 12:45 PM MDT Abstract 2-006 - Dosed to the Max—A Case Report About Bupropion Overdose
Ana Maria Roman, MD
11:45 AM - 12:45 PM MDT Abstract 11-001 - Clinically Meaningful Improvement in Physical Fatigue and Muscle Weakness Fatigability with Rozanolixizumab: Post-hoc Analysis of MG Symptoms PRO Responder Rate in the MycarinG study
Ali A. Habib, MD
11:45 AM - 12:45 PM MDT Abstract 11-002 - Muscle-specific Tyrosine Kinase (MuSK) Autoantibody Measurement of More Than 53,000 Myasthenia Gravis Samples by Radioimmunoprecipitation Method in a Clinical Reference Laboratory Setting
Brandon M. Bauer, PhD
11:45 AM - 12:45 PM MDT Abstract 11-003 - Cost-effectiveness Analysis of Efgartigimod Versus Chronic Intravenous Immunoglobulin (IVIg) for Treatment of Acetylcholine Receptor Antibody Positive (AChR-Ab+) Generalized Myasthenia Gravis (gMG) in Canada
Zaeem A. Siddiqi, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 11-004 - Trial Design and Impact on Study Outcome: Post-hoc Analysis of the BeatMG Study Based on RINOMAX Trial Criteria
Bhaskar Roy, MD
11:45 AM - 12:45 PM MDT Abstract 11-005 - First Cross-sectional Analysis from the ME&MGopen Study: A Decentralized Study on App-based Myasthenia Gravis
Clarissa Gorin, Other
11:45 AM - 12:45 PM MDT Abstract 11-006 - Digital Conversations by Myasthenia Gravis Serostatus
Raghav Govindarajan, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-007 - Ravulizumab Use for Acetylcholine Receptor-positive Generalized Myasthenia Gravis in Clinical Practice
Nakul Katyal, MD
11:45 AM - 12:45 PM MDT Abstract 11-008 - Improvement in Myasthenia Gravis Activities of Daily Living Subdomain Scores in Patients Treated with Eculizumab: Results from a Generalized Myasthenia Gravis Registry Study
Guido Sabatella
11:45 AM - 12:45 PM MDT Abstract 11-009 - A Real-life Experience with Eculizumab and Efgartigimod in Generalized Myasthenia Gravis Patients
Francesco Sacca, MD
11:45 AM - 12:45 PM MDT Abstract 11-010 - Lack of Relationship Between Myasthenia Gravis and COVID-19 Severity
Christelle Haddad, MD
11:45 AM - 12:45 PM MDT Abstract 11-011 - Pre-diagnosis Predictors of High Health Care Cost Among Patients with Myasthenia Gravis Using a Combined Machine-learning and Regression Approach
Jacqueline Pesa, PhD
11:45 AM - 12:45 PM MDT Abstract 11-012 - Eculizumab Versus Rituxmab for Acetylcholine Receptor-positive Generalized Myasthenia Gravis: Single-center Experience
Hacer Durmus, MD
11:45 AM - 12:45 PM MDT Abstract 11-013 - Patient Preferences for Myasthenia Gravis Treatments: A Discrete-choice Experiment
Babak Boroojerdi, MD
11:45 AM - 12:45 PM MDT Abstract 11-014 - Clinical Effectiveness of Efgartigimod in Acetylcholine Receptor-positive Generalized Myasthenia Gravis
Alexis King
11:45 AM - 12:45 PM MDT Abstract 11-015 - Comorbidity Burden and Steroid Use in Generalized Myasthenia Gravis: A Retrospective Analysis of Medicare Fee-for-service Claims
Michael Blackowicz, PhD
11:45 AM - 12:45 PM MDT Abstract 11-016 - Incidence and Prevalence of Myasthenia Gravis: Analysis of a US Commercial Insurance Claims Database
Jennifer Schwinn
11:45 AM - 12:45 PM MDT Abstract 11-017 - Characteristics, Treatment Patterns, and Disease Burden of Juvenile Myasthenia Gravis in the United States
Frank Tennigkeit, PhD
11:45 AM - 12:45 PM MDT Abstract 11-018 - Diagnosis of Lambert-Eaton Myasthenic Syndrome (LEMS) May Be Missed Among Patients with Myasthenia Gravis and Autonomic Dysfunction: Results from a US Database Analysis
Steven Vernino, MD, PhD, FAAN
11:45 AM - 12:45 PM MDT Abstract 11-019 - Uncontrolled Myasthenia Gravis Can Contribute to Additional Stress Burden and Adverse Mental Health Experiences
Kelly G. Gwathmey, MD
11:45 AM - 12:45 PM MDT Abstract 11-020 - Can the Myasthenia Gravis Activities of Daily Life (MG-ADL) Score Predict Sleep Disturbance and Fatigue Among Patients with Myasthenia Gravis?
Christina Marini
11:45 AM - 12:45 PM MDT Abstract 14-001 - Describe the Clinical Course, Diagnostic Approach and Outcomes Following Thymectomy in Four Non-myasthenic Patients with Synaptic Antibody-mediated Autoimmune Neurologic Disease
Aditi Sharma, MBBS
11:45 AM - 12:45 PM MDT Abstract 14-002 - Interactions of Fcγ Receptors with an IgG4 Format, Anti-FcRn Monoclonal Antibody, Rozanolixizumab
Omar Qureshi, PhD
11:45 AM - 12:45 PM MDT Abstract 14-003 - Clinical Characterization of Neurofascin-155 IgG4 and Contactin-1 IgG Dual Positive Neuropathies
Shemonti Hasan, MD
11:45 AM - 12:45 PM MDT Abstract 14-004 - Climate Change Associated with Declining Clinical Outcomes in Myasthenia Gravis for US States with the Greatest Temperature Increase
Kazim Jaffry
11:45 AM - 12:45 PM MDT Abstract 14-005 - Neuromuscular Immune-related Adverse Events of Checkpoint Inhibitors. A Case Series at a Third-level Hospital in Argentina
Rodrigo Joaquin Sanjinez, Sr., MD
11:45 AM - 12:45 PM MDT Abstract 14-006 - Successful Treatment of Concomitant Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome with Autologous CD19-targeted CAR-T Cells
Jeremias Motte, MD
11:45 AM - 12:45 PM MDT Abstract 14-007 - Evaluation of Autoantibody Status Effect on Dermatomyositis Patients’ Response to IVIG Treatment: Post-hoc Analysis of the ProDERM Trial
Mazen M. Dimachkie, MD, FAAN
11:45 AM - 12:45 PM MDT Abstract 14-008 - Nipocalimab a High Affinity, Immunoselective Clinical FcRn Blocker with Unique Properties: Observations from Non-clinical and Clinical Studies
Nilufer Seth, PhD
11:45 AM - 12:45 PM MDT Abstract 14-010 - Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Triggered by Reactivation of Chronic Hepatitis B Infection
Victoria Mazo, MD
11:45 AM - 12:45 PM MDT Abstract 14-011 - A Rare Case of Checkpoint Inhibitor-induced Myasthenia Gravis
Ifrah Waris
11:45 AM - 12:45 PM MDT Abstract 14-012 - A Successful Treatment Story of a Patient with Immune Checkpoint Inhibitor Associated Myositis and Myasthenia Gravis
Jessica Frey, MD
11:45 AM - 12:45 PM MDT Abstract 14-013 - Characterization of the Earliest Adopters of Subcutaneous FcRn Blockers for gMG
Georgiana Kuhlmann
11:45 AM - 12:45 PM MDT Abstract 14-014 - Neurological Immune-related Adverse Events of Immune Checkpoint Inhibitors: A Single-center Retrospective Study
Luca Marsili, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 14-015 - Clinical Characteristics and Outcomes of Neurofascin 186 IgG-associated Neuropathies
Ahmed Ibrahim, MBBCH
11:45 AM - 12:45 PM MDT Abstract 14-016 - Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-mediated Autoimmune Diseases
Tuan Hoang Vu, MD
11:45 AM - 12:45 PM MDT Abstract 14-017 - The Safety and Efficacy of Chronic Weekly Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis (MG0004)
Vera Bril, MD
11:45 AM - 12:45 PM MDT Abstract 14-018 - Preclinical Pharmacology of S-1117, a Novel Engineered Fc-fused IgG Cleaving Enzyme, for Chronic Treatment of Autoantibody-mediated Diseases
Julia Manasson, MD
11:45 AM - 12:45 PM MDT Abstract 14-019 - Subacute Inflammatory Demyelinating Polyneuropathy (SIDP) Secondary to Tumor Necrosis Factor (TNF)-Alpha Inhibitor (Adalimumab) for the Treatment of Rheumatoid Arthritis: A Case Report
Natalie Bartnik, DO
11:45 AM - 12:45 PM MDT Abstract 14-020 - Cerebrovascular Complications in Takayasu's Arteritis: A Middle Cerebral Artery Stroke Case Report
Samir Dhansukh Ruxmohan, DO
11:45 AM - 12:45 PM MDT Abstract 8-001 - Childhood Onset Amyotrophic Lateral Sclerosis Associated with SPTLC2 Gain-of-Function Pathogenic Variants: Clinical, Genetic, and Biochemical Insights
Rotem Orbach, MD
11:45 AM - 12:45 PM MDT Abstract 8-002 - The Impact of a Health Care Transition Clinic on Spina Bifida Condition Management and Transition Planning
Sujal Manohar
11:45 AM - 12:45 PM MDT Abstract 8-003 - A Novel COL11A1 Variant in a Child with Neuromuscular Findings: Expanding the Genotypic and Phenotypic Spectrum of COL11A1-related Disease
Meghan McAnally, MD
11:45 AM - 12:45 PM MDT Abstract 8-004 - Safety of Different Pharmacological Treatments in Boys with Duchenne Muscular Dystrophy: A Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials
Amanda Cyntia Lima Fonseca Rodrigues
11:45 AM - 12:45 PM MDT Abstract 8-005 - Phenotypic Variability of Seronegative Myasthenia Gravis in Children
Alexander James Fay, MD, PhD
11:45 AM - 12:45 PM MDT Abstract 8-006 - Dystrophinopathies in Children with Normal Creatinine Kinase Levels: A Case Series
Dhanalakshmi Angappan, MD
11:45 AM - 12:45 PM MDT Abstract 8-007 - Phase 1/2 Trial Evaluating AOC 1044 in Healthy Volunteers and Participants with DMD Mutations Amenable to Exon 44 Skipping (DMD44): EXPLORE44 Trial Design
Marc Morris, MD
Faculty Disclosures
Jennifer McGuire, MD No disclosure on file
David Gerhard Coughlin, MD The institution of Dr. Coughlin has received research support from American Academy of Neurology. The institution of Dr. Coughlin has received research support from NIA. The institution of Dr. Coughlin has received research support from NINDS.
Heidi Grace Standke Ms. Standke has nothing to disclose.
Varun Sai Rachakonda Mr. Rachakonda has nothing to disclose.
Mikayla Huntley, Other Ms. Huntley has nothing to disclose.
Caitlin Swanberg Miss Swanberg has nothing to disclose.
Thea Andreasson, Other Ms. Andreasson has nothing to disclose.
Yongya Kim Mr. Kim has nothing to disclose.
Matteo Manca, PhD Dr. Manca has nothing to disclose.
Olivia Thomas, Other Miss Thomas has nothing to disclose.
Douglas Galasko, MD Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for vTv Therapeutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BioMed Central.
Allison Kraus, PhD Prof. Kraus has nothing to disclose.
Anne Elizabeth Hiniker, MD No disclosure on file
Alexander J. Gill, MD, PhD Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medical Logix, LLC. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Health Union, LLC . Dr. Gill has received research support from National Multiple Sclerosis Society.
Kellyann Niotis, MD Dr. Niotis has nothing to disclose.
Alon Seifan, MD Dr. Seifan has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Science Officer with HB Biotech.
Shannon Helfman, Other Ms. Helfman has received personal compensation for serving as an employee of The Institute for Neurodegenerative Diseases of Florida.
Praveen S. Parthasarathy Mr. Parthasarathy has nothing to disclose.
Hollie Hristov, NP Mrs. Hristov has nothing to disclose.
Juan Antonio Melendez-Herencia, MD Dr. Melendez-Herencia has nothing to disclose.
Christopher Michael Janney, PhD Dr. Janney has received personal compensation for serving as an employee of The Institute for Neurodegenerative Diseases (IND) Florida. Dr. Janney has received personal compensation for serving as an employee of HCW Biologics. Dr. Janney has stock in HCW Biologics.
Richard S. Isaacson, MD, FAAN Dr. Isaacson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Isaacson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Hanna Huber, PhD The institution of Dr. Huber has received research support from Bonner Forum Biomedizin. The institution of Dr. Huber has received research support from German Federal Ministry of Research. The institution of Dr. Huber has received research support from Demensförbundet. The institution of Dr. Huber has received research support from Adlerbertska forskningsstiftelsen.
Nicholas James Ashton, PhD Dr. Ashton has nothing to disclose.
Henrik Zetterberg Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Acumen. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for AlzPATH. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Apellis. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Fujirebio. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Philip Edward Sisser Mr. Sisser has received personal compensation for serving as an employee of PAREF.
Helena Colvee, Other Miss Colvee has received personal compensation in the range of $500-$4,999 for serving as a Research Assistant with IND .
Jessica Lakis, Other Ms. Lakis has received personal compensation for serving as an employee of Retain Health . Ms. Lakis has stock in Retain Health.
Kiarra Akiyoshi Ms. Akiyoshi has nothing to disclose.
Steven Douglas No disclosure on file
Anuttham Kandhadai Mr. Kandhadai has nothing to disclose.
Paul Brindley, MD Dr. Brindley has nothing to disclose.
Dennis L. Kolson, MD,PhD No disclosure on file
Alma *USE ID 327908 Ghirelli, MD Dr. Ghirelli has nothing to disclose.
Edoardo G. Spinelli, MD Dr. Spinelli has nothing to disclose.
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Silvia Basaia Silvia Basaia has nothing to disclose.
Veronica Castelnovo, MSc Dr. Castelnovo has nothing to disclose.
Giordano Cecchetti Giordano Cecchetti has nothing to disclose.
Elisa Sibilla, Other Dr. Sibilla has nothing to disclose.
Giuseppe Magnani Giuseppe Magnani has nothing to disclose.
Francesca Caso, MD Dr. Caso has nothing to disclose.
Paola Caroppo Paola Caroppo has nothing to disclose.
Sara Prioni Sara Prioni has nothing to disclose.
Cristina Villa, Other Miss Villa has nothing to disclose.
Lucio Tremolizzo Lucio Tremolizzo has nothing to disclose.
Ildebrando H. Appollonio, MD Dr. Appollonio has nothing to disclose.
Federico Verde No disclosure on file
Nicola Ticozzi, MD The institution of Dr. Ticozzi has received research support from Italian Ministry of Health . The institution of Dr. Ticozzi has received research support from AriSLA.
Vincenzo Silani, MD, FAAN Dr. Silani has nothing to disclose.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Sasha Zivkovic, MD, FAAN Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam .
Aline Thomas, PhD Dr. Thomas has nothing to disclose.
Danurys Sanchez Ms. Sanchez has nothing to disclose.
Dolly Reyes-Dumeyer, Other Mrs. Reyes-Dumeyer has nothing to disclose.
Richard P. Mayeux, MD, MSc, FAAN Dr. Mayeux has nothing to disclose.
Yian Gu, PhD The institution of Dr. Gu has received research support from NIH.
Anne C. Van Cott, MD, FAAN Dr. Van Cott has nothing to disclose.
Kexin Li, MD, PhD Dr. Li has nothing to disclose.
Lily Jan, PhD The institution of Prof. Jan has received research support from Howard Hughs Medical Institute. The institution of Prof. Jan has received research support from NIH.
Chin-Fen Teo, PhD Dr. Teo has nothing to disclose.
Huned S. Patwa, MD, FAAN No disclosure on file
John M. Ravits, MD, FAAN Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iris, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze, Inc. Dr. Ravits has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Transposon, Inc. Dr. Ravits has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Libra, Inc. The institution of Dr. Ravits has received research support from NIH R21 Research Grant. The institution of Dr. Ravits has received research support from NIH R01 Research Grant. The institution of Dr. Ravits has received research support from FightMND Foundation Research Grant. The institution of Dr. Ravits has received research support from DOD Research Grant. Dr. Ravits has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH Office of Scientific Review.
Isabel Costantino Ms. Costantino has nothing to disclose.
Mary Jo Pugh, PhD, RN, FAAN The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs. The institution of Dr. Pugh has received research support from Sanofi.
Jennifer Louise Whitwell, PhD Dr. Whitwell has nothing to disclose.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Val John Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Michelle M. Mielke, PhD Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Neha Atulkumar Singh, PhD Dr. Singh has nothing to disclose.
Matthew Senjem Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai.
Christopher Schwarz Christopher Schwarz has received personal compensation for serving as an employee of Mayo Clinic. The institution of Christopher Schwarz has received research support from NIH.
Danni Li, PhD The institution of Dr. Li has received research support from NIH. Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Juan Llibre No disclosure on file
Joseph Isaac Turner Mr. Turner has nothing to disclose.
Michael Ferguson, PhD Dr. Ferguson has nothing to disclose.
Jared A Nielsen, PhD Prof. Nielsen has nothing to disclose.
Anish Suvarna Mr. Suvarna has nothing to disclose.
Vicky Chen Ms. Chen has nothing to disclose.
Elijah Baughan, Other Mr. Baughan has nothing to disclose.
Kiana Bunnell, Other Ms. Bunnell has nothing to disclose.
Frederic Schaper, MD, PhD Dr. Schaper has nothing to disclose.
Jose Jordan No disclosure on file
Molly Kate Wiggins, MD Dr. Wiggins has nothing to disclose.
Nikita Jain, MD Dr. Jain has nothing to disclose.
Jessica Tate, MD The institution of Dr. Tate has received research support from Ipsen. The institution of Dr. Tate has received research support from Boston Scientific. The institution of Dr. Tate has received research support from Revance Therapeutics. The institution of Dr. Tate has received research support from CHDI Foundation. The institution of Dr. Tate has received research support from NINDS. The institution of Dr. Tate has received research support from Michael J. Fox Foundation.
Amelia Kirby, MD Dr. Kirby has nothing to disclose.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
James R. Bateman, III, MD Dr. Bateman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Bateman has received research support from NIA. The institution of Dr. Bateman has received research support from Dementia Alliance of North Carolina. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Drug Discovery Foundation. Dr. Bateman has a non-compensated relationship as a Committee Member with UCNS that is relevant to AAN interests or activities.
Zesong Yang No disclosure on file
Zi-Yue Liu Zi-Yue Liu has nothing to disclose.
Pei Wang, MD Dr. Wang has nothing to disclose.
Feifei Zhai No disclosure on file
Dong-Hui Ao Dr. Ao has nothing to disclose.
Fei Han No disclosure on file
Ming-Li Li Ming-Li Li has nothing to disclose.
Lixin Zhou Lixin Zhou has nothing to disclose.
Jun Ni Jun Ni has nothing to disclose.
Ming Yao No disclosure on file
Shu-Yang Zhang The institution of Shu-Yang Zhang has received research support from Chinese Academy of Medical Science.
Liying Cui, PhD No disclosure on file
Zhengyu Jin Dr. Jin has nothing to disclose.
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Jun Mu, MD, PhD No disclosure on file
Peiyang Gao, MD Dr. Gao has nothing to disclose.
Jintai Yu No disclosure on file
Lan Tan No disclosure on file
Ya-Nan Ou Dr. Ou has nothing to disclose.
Mohammad Abdurrehman Sheikh, MBBS Dr. Sheikh has nothing to disclose.
Mitchell S. V. Elkind, MD, MS, FAAN Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy. The institution of Dr. Elkind has received research support from BMS-Pfizer Alliance for Eliquis. The institution of Dr. Elkind has received research support from Roche. Dr. Elkind has received publishing royalties from a publication relating to health care. Dr. Elkind has a non-compensated relationship as a Officer with American Heart Association that is relevant to AAN interests or activities.
Yeseon Moon No disclosure on file
Clinton B. Wright, MD, FAAN An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MARSHALL DENNEHY. The institution of an immediate family member of Dr. Wright has received research support from Oncospace. Dr. Wright has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Wright has received personal compensation in the range of $500-$4,999 for serving as a surveyor with ASTRO.
Jose Gutierrez, MD Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Roetzel & Andress, JOHN ASTUNO, JR. L.L.C.. The institution of Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care.
Tatjana Rundek, MD, PhD The institution of Dr. Rundek has received research support from NIH.
Ken Cheung Ken Cheung has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Deck Therapeutics.
Mady Hornig The institution of Mady Hornig has received research support from NIH. The institution of Mady Hornig has received research support from The Korein Family Foundation.
Benjamin Friedman Benjamin Friedman has nothing to disclose.
Elif Pinar Coskun, MD Dr. Coskun has nothing to disclose.
Justin Barber Justin Barber has nothing to disclose.
Erin Abner The institution of Erin Abner has received research support from National Institutes of Health.
Richard J. Kryscio, PhD Dr. Kryscio has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Kryscio has received research support from NIH. Dr. Kryscio has received personal compensation in the range of $500-$4,999 for serving as a member PCNS Scientific Advisory Board with FDA.
Frederick A. Schmitt, PhD The institution of Dr. Schmitt has received research support from NIH.
Linda Van Eldik The institution of Linda Van Eldik has received research support from NIH. The institution of Linda Van Eldik has received research support from ADDF. Linda Van Eldik has received intellectual property interests from a discovery or technology relating to health care. Linda Van Eldik has received personal compensation in the range of $0-$499 for serving as a Study section reviewer with NIH.
Peter T. Nelson Peter T. Nelson has nothing to disclose.
Gregory A. Jicha, MD, PhD Dr. Jicha has nothing to disclose.
Brian Gold No disclosure on file
Larry R. Faulkner, MD Dr. Faulkner has received personal compensation for serving as an employee of ABPN.
Fuling Yan No disclosure on file
Huiqing Wang, III, PhD Dr. ? has nothing to disclose.
Dorthea Juul, PhD Dr. Juul has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology.
Sanaea Zubin Bhagwagar An immediate family member of Miss Bhagwagar has received personal compensation for serving as an employee of three different biotech companies unrelated to the present submission.
Hideyuki Takahashi, PhD Dr. Takahashi has nothing to disclose.
Stephen M. Strittmatter, MD,PhD Dr. Strittmatter has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allyx. Dr. Strittmatter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Proteowise. Dr. Strittmatter has stock in Allyx. Dr. Strittmatter has stock in Proteowise. Dr. Strittmatter has stock in ReNetX. The institution of Dr. Strittmatter has received research support from Proteowise. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care.
Abuhuzeifa Abubakr, MB, FRCP, FRCPI,FAAN No disclosure on file
Bhavya Bakshi Mr. Bakshi has nothing to disclose.
Michael Tiemeyer, PhD Dr. Tiemeyer has nothing to disclose.
Katelyn Rosenbalm, PhD Dr. Rosenbalm has received research support from Versiti Blood Research Institute.
Ilse Wambacq No disclosure on file
Tony Zhang, MBChB Dr. Zhang has nothing to disclose.
Neil Anderson, MD Dr. Anderson has nothing to disclose.
Jae Beom Hong, MBChB Dr. Hong has nothing to disclose.
Andrew M. Chancellor, "MD, FRACP" No disclosure on file
David Ormond Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Edward Wong, MD Dr. Wong has nothing to disclose.
Nicholas Child, MD Dr. Child has nothing to disclose.
Yi-Chu Liao, MD Dr. Liao has nothing to disclose.
Emma Glamuzina, FRACP Dr. Glamuzina has received personal compensation in the range of $0-$499 for serving as a Rare Disease Subcommittee member with Pharmac New Zealand.
Yi-Chung Lee, MD, FAAN Dr. Lee has nothing to disclose.
Jacqueline Ann Nicholas, MD Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vielo Bio. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Nicholas has received research support from Novartis. The institution of Dr. Nicholas has received research support from Biogen. The institution of Dr. Nicholas has received research support from Genentech. The institution of Dr. Nicholas has received research support from PCORI. Dr. Nicholas has a non-compensated relationship as a Physician with National MS Society that is relevant to AAN interests or activities. Dr. Nicholas has a non-compensated relationship as a Physician with Siegal Rare Neuroimmune Association that is relevant to AAN interests or activities.
Aditi *Use 317067 Sharma, MD Dr. Sharma has nothing to disclose.
Tammy L. Smith, MD, PhD The institution of Dr. Smith has received research support from Alexion/AstraZeneca. Dr. Smith has a non-compensated relationship as a participant with Euroimmun Academy, receiving travel support to attend, that is relevant to AAN interests or activities.
Melissa Ann Wright, MD Dr. Wright has nothing to disclose.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation .
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Jonathan Ross Galli, MD Dr. Galli has nothing to disclose.
Robert Kadish, MD Dr. Kadish has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Kadish has received research support from Alexion Pharmaceuticals.
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from Sumaira Foundation for NMO. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory.
M. Mateo Paz Soldan, MD, PhD Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Aaron L. Boster, MD Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for roche. Dr. Boster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Boster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Serono. The institution of Dr. Boster has received research support from Sanofi. The institution of Dr. Boster has received research support from Roche.
Omar Qureshi, PhD Dr. Qureshi has received personal compensation for serving as an employee of Celentyx Ltd. Dr. Qureshi has received personal compensation for serving as an employee of UCB Pharma. Dr. Qureshi has stock in Celentyx.
Rosemary Bithell, PhD Dr. Bithell has nothing to disclose.
Rona Marie Cutler Miss Cutler has received personal compensation for serving as an employee of UCB.
Gillian McCluskey, Other Ms. McCluskey has received personal compensation for serving as an employee of AstraZeneca.
Graham Craggs, PhD Dr. Craggs has received personal compensation for serving as an employee of Dark Blue Therapeutics Ltd. Dr. Craggs has received personal compensation for serving as an employee of e-therapeutics plc.
Nicholas Barnes, PhD Prof. Barnes has received personal compensation for serving as an employee of Celentyx Ltd. Prof. Barnes has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Prof. Barnes has stock in Celentyx Ltd. The institution of Prof. Barnes has received research support from MRC.
David Paul Humphreys, PhD Dr. Humphreys has received personal compensation for serving as an employee of UCB Pharma. Dr. Humphreys has stock in UCB Pharma.
Stephen Edward Rapecki, PhD Dr. Rapecki has stock in UCB.
Bryan John Smith, PhD Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Smith has stock in UCB.
Anthony Shock Anthony Shock has received personal compensation for serving as an employee of UCB Pharma.
Gary A. Mellick, DO No disclosure on file
Shemonti Hasan, MD Dr. Hasan has nothing to disclose.
Haidara Kherbek, MD Dr. Kherbek has nothing to disclose.
Pallab Sarker, MBBS Dr. Sarker has nothing to disclose.
Yoonjae Nam, Other Mr. Nam has nothing to disclose.
Aaron L. Berkowitz, MD, PhD, FAAN Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill Education. Dr. Berkowitz has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Clinical problem Solvers. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Thieme Publisher.
Alan David Salgado, MD Dr. Salgado has nothing to disclose.
Kyle Alexander Wuthrich, DO Dr. Wuthrich has nothing to disclose.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Faze Medicine .
John R. Mills, MD, PhD The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care.
Divyanshu Dubey, MD, FAAN The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Dubey has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Moffit Cancer Center . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Larry Mellick, MD No disclosure on file
Kazim Jaffry Mr. Jaffry has nothing to disclose.
Scott Lawrence Karpenos Mr. Karpenos has nothing to disclose.
James Lin, MS Mr. Lin has nothing to disclose.
Justin *Use 400777 Matos Mr. Matos has nothing to disclose.
Kranthi Kiran Mandava Mr. Mandava has nothing to disclose.
Suhayb Islam Mr. Islam has nothing to disclose.
Narjis Jaffry, Other Miss Jaffry has nothing to disclose.
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
William Hamilton No disclosure on file
Rodrigo Joaquin Sanjinez, Sr., MD Dr. Sanjinez has nothing to disclose.
Marcelo Rugiero Rodriguez Marcelo Rugiero Rodriguez has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Agustina Moroni, MD Miss Moroni has nothing to disclose.
Lucia Belen Varela Miss Varela has nothing to disclose.
Mariela Bettini, MD Dr. Bettini has nothing to disclose.
Facundo Silveira Facundo Silveira has nothing to disclose.
Pablo Sosa Dr. Sosa has nothing to disclose.
Carolina Laura Azcona, MD Dr. Azcona has nothing to disclose.
Rocio Veronica Marquez, MD Dr. Marquez has nothing to disclose.
Haijuan Huang No disclosure on file
Jeremias Motte, MD The institution of Dr. Motte has received research support from Ruhr-Univerity Bochum.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Melissa Sgodzai Melissa Sgodzai has nothing to disclose.
Christiane Schneider-Gold No disclosure on file
Dominic Borie, MD,PhD Dr. Borie has received personal compensation for serving as an employee of Kyverna Therapeutics Inc. Dr. Borie has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Kyverna Therapeutics Inc. Dr. Borie has stock in Kyverna Therapeutics.
Tobias Hegelmaier Dr. Hegelmaier has nothing to disclose.
Aiden Haghikia, MD Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene.
Dimitrios Mougiakakos, MD Prof. Mougiakakos has nothing to disclose.
Roland Schroers No disclosure on file
Eric Seiber No disclosure on file
Rohit Aggarwal, MD Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kezar. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenex. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BI. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Q32. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Corbus. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. The institution of Dr. Aggarwal has received research support from Genentech. The institution of Dr. Aggarwal has received research support from Mallinckodt. The institution of Dr. Aggarwal has received research support from BMS. The institution of Dr. Aggarwal has received research support from EMD Serono. The institution of Dr. Aggarwal has received research support from Q32.
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1 Capital, LLC. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cello Health BioConsulting, previously Defined Health. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RAF-5. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Houston NeuroCare. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shire. Dr. Dimachkie has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RaPharma/UCB. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. An immediate family member of Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SCHOLAR Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jenssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amazentis / Vandria. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANEM. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme . Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Covance / Labcorp. The institution of Dr. Dimachkie has received research support from CSL Behring. The institution of Dr. Dimachkie has received research support from Orphazyme. The institution of Dr. Dimachkie has received research support from FDA-OOPD. The institution of Dr. Dimachkie has received research support from NIH. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Christina Charles-Schoeman, MD Dr. Charles-Schoeman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Charles-Schoeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Charles-Schoeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gilead. Dr. Charles-Schoeman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Regeneron. Dr. Charles-Schoeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gilead. Dr. Charles-Schoeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Charles-Schoeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron-Sanofi. The institution of Dr. Charles-Schoeman has received research support from Bristol-Myers Squibb. The institution of Dr. Charles-Schoeman has received research support from Pfizer. The institution of Dr. Charles-Schoeman has received research support from Abbvie.
Joachim Schessl, MD Dr. Schessl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma.
Elisabeth Clodi, PhD Dr. Clodi has received personal compensation for serving as an employee of Octapharma Pharmazeutika Produktionsges.m.b.H..
Warren D. Lo, MD, FAAN The institution of Dr. Lo has received research support from NIH. Dr. Lo has received publishing royalties from a publication relating to health care.
Nilufer Seth, PhD Dr. Seth has received personal compensation for serving as an employee of J&J Innovative Medicines .
Rui Xu, PhD Dr. Xu has nothing to disclose.
Leona Ling, PhD Dr. Ling has received personal compensation for serving as an employee of Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has stock in Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has received intellectual property interests from a discovery or technology relating to health care. Dr. Ling has received intellectual property interests from a discovery or technology relating to health care.
Traymon Beavers, PhD Mr. Beavers has received personal compensation for serving as an employee of Johnson & Johnson. Mr. Beavers has stock in Apple. Mr. Beavers has stock in Amazon.
Viraj Parge Mr. Parge has received personal compensation for serving as an employee of Johnson and Johnson Innovative Medicine. Mr. Parge has stock in Johnson and Johnson Innovative Medicine.
Steven M. Tyler, Other Mr. Tyler has received personal compensation for serving as an employee of AVROBIO, INC . Mr. Tyler has received personal compensation for serving as an employee of Orna Therapeutics. Mr. Tyler has received personal compensation for serving as an employee of Genevant Sciences.
William Avery, PhD Dr. Avery has received personal compensation for serving as an employee of Lyndra Therapeutics. Dr. Avery has received personal compensation for serving as an employee of Xilio Therapeutics. Dr. Avery has received personal compensation for serving as an employee of Kisbee Therapeutics. Dr. Avery has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta Pharmaceutical. Dr. Avery has received stock or an ownership interest from Life Biosciences.
Sam Sihapong Sam Sihapong has received personal compensation for serving as an employee of Johnson and Johnson .
Julia Brown, PhD Dr. Brown has received personal compensation for serving as an employee of Janssen Pharmaceuticals. Dr. Brown has received personal compensation for serving as an employee of Momenta Pharmaceuticals. Dr. Brown has received stock or an ownership interest from Janssen Pharmaceuticals. Dr. Brown has received stock or an ownership interest from Momenta Pharmaceuticals. Dr. Brown has received intellectual property interests from a discovery or technology relating to health care.
Sindhu Ramchandren, MD Dr. Ramchandren has received personal compensation for serving as an employee of Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Ramchandren has a non-compensated relationship as a Scientific Advisory Board Member with CMT Research Foundation (CMTRF) that is relevant to AAN interests or activities.
Hong Sun, MD, PhD Dr. Sun has received personal compensation for serving as an employee of Janssen.
Kristin Heerlein, MD,PhD Dr. Heerlein has received personal compensation for serving as an employee of Johnson and Johnson Innovative Medicine. Dr. Heerlein has stock in Johnson and Johnson Innovative Medicine.
Katie Abouzahr Katie Abouzahr has received personal compensation for serving as an employee of Johnson and Johnson. Katie Abouzahr has stock in Johnson and Johnson.
Sayak Bhattacharya, PhD Dr. Bhattacharya has nothing to disclose.
Monika Mishra, MD Dr. Mishra has nothing to disclose.
Henk-Andre A Kroon, MD, MBA Dr. Kroon has received personal compensation for serving as an employee of Annexon Biosciences. Dr. Kroon has stock in Annexon Biosciences.
Kunal Kanani, Other Dr. Kanani has received personal compensation for serving as an employee of Annexon Bio. Dr. Kanani has stock in Annexon Bio.
Eric Humphriss Eric Humphriss has received personal compensation for serving as an employee of Annexon Biosciences. Eric Humphriss has received stock or an ownership interest from Annexon Biosciences.
Preeti Paliwal, PhD Ms. Paliwal has received personal compensation for serving as an employee of Annexon Biosciences .
Benjamin Hoehn, MD,PhD Dr. Hoehn has received personal compensation for serving as an employee of Annexon Bioscience. Dr. Hoehn has stock in Annexon bioscience.
Christos Stylianou, PhD Dr. Stylianou has received personal compensation for serving as an employee of ClinBAY ltd. Dr. Stylianou has received personal compensation for serving as an employee of Cyprus College. Dr. Stylianou has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ClinBAY ltd.
Zhahirul Islam Zhahirul Islam has nothing to disclose.
Nowshin Papri Nowshin Papri has nothing to disclose.
Quazi Deen Mohammad, MD Dr. Deen Mohammad has nothing to disclose.
AJ Acker Mr. Acker has nothing to disclose.
Lily Parker, Other Ms. Parker has nothing to disclose.
Naveen Perisetla Mr. Perisetla has nothing to disclose.
Victoria Mazo, MD Dr. Mazo has nothing to disclose.
Natasha Nicole Llanes, MD Dr. Llanes has nothing to disclose.
Anthony M. Bradshaw, MD Dr. Bradshaw has nothing to disclose.
Vishunmurthy Shushrutha Hedna, MD No disclosure on file
Axel Manuel Baez-Lugo, MD Dr. Baez-Lugo has nothing to disclose.
Ifrah Waris Ms. Waris has nothing to disclose.
Anusha Gadipudi Miss Gadipudi has nothing to disclose.
Ashley Vincenty-Acosta Miss Vincenty-Acosta has nothing to disclose.
Gerald Wallace, IV, MD Dr. Wallace has nothing to disclose.
Ivan Adamec Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz. Ivan Adamec has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zentiva.
Hongxuyang Yu, MD Dr. Yu has nothing to disclose.
Jessica Frey, MD The institution of Dr. Frey has received research support from Tourette Association of America.
Andrew Beiter, MD Dr. Beiter has nothing to disclose.
Magdalena Krbot Skoric Magdalena Krbot Skoric has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Blaine Cloud, PhD Dr. Cloud has nothing to disclose.
Georgiana Kuhlmann Georgiana Kuhlmann has stock in Amgen.
Mario Habek, MD Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Luca Marsili, MD, PhD Dr. Marsili has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IAPRD. Dr. Marsili has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia.
Kevin R. Duque Dr. Duque has nothing to disclose.
Samuel Blaise Marcucci, MD The institution of Mr. Marcucci has received research support from Foundation of the Consortium of Multiple Sclerosis Centers.
Martina Chirra, MD Dr. Chirra has nothing to disclose.
Joseph Christopher LaPorta Mr. LaPorta has nothing to disclose.
Jesus Abanto Mr. Abanto has received personal compensation for serving as an employee of University of Cincinnati .
Alberto Vogrig, MD,PhD Dr. Vogrig has nothing to disclose.
Alberto J. Espay, MD, FAAN Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus (formerly, USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avion Pharmaceuticals. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Ernst-Wilhelm *167769 Radue, MD No disclosure on file
Ahmed Ibrahim, MBBCH Dr. Ibrahim has nothing to disclose.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Dusan Stefoski, MD, FAAN No disclosure on file
Tuan Hoang Vu, MD Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImmunAbs. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from Amylyx Pharma. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Annexon. The institution of Dr. Vu has received research support from Horizon. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Momenta. The institution of Dr. Vu has received research support from Immunovant.
Kelly G. Gwathmey, MD Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Catherine Broome, MD Dr. Broome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Broome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Broome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Broome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incyte. The institution of Dr. Broome has received research support from Argenx. The institution of Dr. Broome has received research support from Sanofi. The institution of Dr. Broome has received research support from Incyte. The institution of Dr. Broome has received research support from Rigel.
Matthias Goebeler, MD Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. The institution of Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GSK. Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Prof. Goebeler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. The institution of Prof. Goebeler has received research support from Argenx. Prof. Goebeler has received personal compensation in the range of $0-$499 for serving as a travel expenses with UCB.
Hiroyuki Murai, MD Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical. The institution of Dr. Murai has received research support from Japan Blood Products Organization.
Zsuzsanna Bata-Csorgo, MD,PhD Prof. Bata-Csorgo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme Hungary. The institution of Prof. Bata-Csorgo has received research support from NKFI Hungary. Prof. Bata-Csorgo has received publishing royalties from a publication relating to health care.
Adrian Charles Newland, MD Prof. Newland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OakHill Bio. Prof. Newland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Prof. Newland has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Angle PLC. Prof. Newland has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. Prof. Newland has received personal compensation in the range of $10,000-$49,999 for serving as a Chair, Clinical Board with BMI Healthcare.
Peter Ulrichts Peter Ulrichts has received personal compensation for serving as an employee of argenx. Peter Ulrichts has stock in argenx.
Rene Kerstens, Other Mr. Kerstens has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Argenx.
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has stock in argenx.
Sofiane Agha Dr. Agha has received personal compensation for serving as an employee of argenx. Dr. Agha has stock in argenx.
Ming Jiang, MD Mrs. Jiang has received personal compensation for serving as an employee of argenx BV.
James F. Howard, Jr., MD, FAAN Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for arenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ra Pharma (now UCB Biosciences). Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi US. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Zai Laboratories. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medscape CME. Dr. Howard has stock in General Electric dividends. Dr. Howard has stock in Johnson & Johnson dividends. Dr. Howard has stock in Pfizer dividends. An immediate family member of Dr. Howard has stock in GlaxoSmithKline dividends. An immediate family member of Dr. Howard has stock in GE Healthcare dividends. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Duke University (DCRI). The institution of Dr. Howard has received research support from Cartestian Therapeutics. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
No disclosure on file
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Artur Druzdz, PhD Dr. Druzdz has nothing to disclose.
Julian Grosskreutz Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Grosskreutz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grosskreutz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. The institution of Dr. Grosskreutz has received research support from Boris Canessa Foundation.
Ali A. Habib, MD Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Immune Sciences. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from VielaBio. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Genentech. The institution of Dr. Habib has received research support from Regeneron.
Henry J. Kaminski, MD, FAAN The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Kaminski has stock in ARC Biotechnology. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Renato Mantegazza, MD Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mantegazza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERB. The institution of Dr. Mantegazza has received research support from Alpine Immune Sciences, Inc.
Sabrina Sacconi, MD Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LUPIN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMICUS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FULCRUM THERAPEUTICS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AXELYS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for OLOGY. The institution of Dr. Sacconi has received research support from Solve FSHD.
Kimiaki Utsugisawa, MD,PhD Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Utsugisawa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubisi Tanabe pharma. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion phama. Dr. Utsugisawa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Japan Blood Products Organization. Dr. Utsugisawa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Marion Boehnlein Marion Boehnlein has received personal compensation for serving as an employee of UCB Pharma. Marion Boehnlein has stock in UCB Pharma.
Franz Woltering Franz Woltering has received personal compensation for serving as an employee of UCB Biosciences GmbH. Franz Woltering has stock in UCB.
Bernhard Greve, MD Dr. Greve has received personal compensation for serving as an employee of UCB Biosciences. Dr. Greve has stock in UCB Biosciences.
Maryam Gayfieva, MD Dr. Gayfieva has nothing to disclose.
John Vissing, MD Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genethon. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lupin. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from UCB Pharma. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from NOVO Foundation. Prof. Vissing has received research support from Reneo Pharma. Prof. Vissing has received research support from Janssen Pharmaceuticals.
Manjit McNeill Manjit McNeill has nothing to disclose.
Ivan Mascanfroni Dr. Mascanfroni has nothing to disclose.
Julia Manasson, MD Dr. Manasson has received personal compensation for serving as an employee of Seismic Therapeutic. Dr. Manasson has stock in Seismic Therapeutic. The institution of Dr. Manasson has received research support from Rheumatology Research Foundation.
Alex Pellerin, PhD Dr. Pellerin has received personal compensation for serving as an employee of Biogen. An immediate family member of Dr. Pellerin has stock in Biogen.
Liliana Maria Sanmarco, Jr., PhD Dr. Sanmarco has received personal compensation for serving as an employee of Seismic Therapeutic.
Jordan M. Anderson, PhD Dr. Anderson has received personal compensation for serving as an employee of Seismic Therapeutic, Inc. Dr. Anderson has stock in Seismic Therapeutic, Inc.
Nathan Rollins, PhD Dr. Rollins has received personal compensation for serving as an employee of Seismic Therapeutic. Dr. Rollins has stock in Seismic Therapeutic.
Andita Newton Andita Newton has received personal compensation for serving as an employee of Seismic Therapeutic.
Ryan Peckner Ryan Peckner has received personal compensation for serving as an employee of Seismic Therapeutic. Ryan Peckner has stock in Seismic Therapeutic.
Yi Xing, PhD Dr. Xing has nothing to disclose.
Nathan Higginson-Scott Dr. Higginson-Scott has received personal compensation for serving as an employee of Seismic Therapeutic.
John Sundy, MD,PhD Dr. Sundy has received personal compensation for serving as an employee of Seismic Therapeutic. Dr. Sundy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tome Biosciences. Dr. Sundy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rome Therapeutics. Dr. Sundy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upstream Bio. Dr. Sundy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Imhotex. Dr. Sundy has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Neutrolis, Inc. Dr. Sundy has stock in Gilead Sciences. Dr. Sundy has stock in Seismic Therapeutic. Dr. Sundy has stock in Rome Therapeutics. Dr. Sundy has stock in Upstream Bio. Dr. Sundy has stock in Neutrolis.
Kevin Otipoby No disclosure on file
Katherine A. Riester, MPH No disclosure on file
Natalie Bartnik, DO Dr. Bartnik has nothing to disclose.
Mark Grady, MD Dr. Grady has nothing to disclose.
Laith N. Maali, MD Dr. Maali has nothing to disclose.
Sean Thomas Beattie, DO Dr. Beattie has nothing to disclose.
Jacob S. Elkins, MD No disclosure on file
Jonathan Quinonez, DO Dr. Quinonez has nothing to disclose.
Samir Dhansukh Ruxmohan, DO Dr. Ruxmohan has nothing to disclose.
Juliana Cazzaniga Miss Cazzaniga has nothing to disclose.
Marie Christine Brunet No disclosure on file
Rotem Orbach, MD Dr. Orbach has nothing to disclose.
Safoora Bakhtiyar Syeda, MBBS No disclosure on file
Payam Mohassel, MD The institution of Dr. Mohassel has received research support from NIH. The institution of Dr. Mohassel has received research support from DoD. The institution of Dr. Mohassel has received research support from Million Dollar Bike Ride UPenn.
Maike Dohrn, MD Dr. Dohrn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea, Alnylam, Pfizer, Amicus. Dr. Dohrn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus, Akcea. Dr. Dohrn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea, Alnylam, Pfizer. The institution of Dr. Dohrn has received research support from Pfizer. Dr. Dohrn has received research support from German Research Foundation.
Museer A. Lone, PhD Dr. Lone has nothing to disclose.
Sandra Donkervoort Ms. Donkervoort has nothing to disclose.
A. Reghan Foley A. Reghan Foley has nothing to disclose.
Danique Beijer, PhD Dr. Beijer has nothing to disclose.
Elif Bayraktar No disclosure on file
Piraye Oflazer, MD Prof. University has nothing to disclose.
Pinki Munot Dr. Munot has nothing to disclose.
Aubrey L. Rose, Other Miss Rose has nothing to disclose.
Michael Lyons Dr. Lyons has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina.
Raymond J. Louie, PhD Dr. Louie has nothing to disclose.
Kenneth Gable Mr. Gable has nothing to disclose.
MARCONDES *Use 140311 CAVALCANTE FRANCA, Jr. Dr. CAVALCANTE FRANCA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. CAVALCANTE FRANCA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. CAVALCANTE FRANCA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. CAVALCANTE FRANCA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. CAVALCANTE FRANCA has received research support from FARA.
Juan Eli Galarza-Brito, II, MD Dr. GALARZA-BRITO has nothing to disclose.
Matthias Eckenweiler, MD Dr. Eckenweiler has nothing to disclose.
Alexander Asamoah, MD,PhD Dr. Asamoah has nothing to disclose.
Anirban Majumdar, MBBS Dr. Majumdar has nothing to disclose.
Perry Shieh, MD, PhD, FAAN Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
Anke Schumann No disclosure on file
Sita D. Gupta, PhD Ms. Gupta has nothing to disclose.
Arpita Lakhotia, MD Dr. Lakhotia has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Kelly Elaine Jackson, Other Ms. JACKSON has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Katherine Chao, Other Mrs. Chao has nothing to disclose.
Thomas L. Winder, PhD, FACMG Dr. Winder has nothing to disclose.
Francesco Catapano, PhD Dr. Catapano has nothing to disclose.
Lucy Feng, PhD Dr. Feng has nothing to disclose.
Janbernd Kirschner Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genethon. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Italfarmaco. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. The institution of Janbernd Kirschner has received research support from Roche. The institution of Janbernd Kirschner has received research support from Biogen. The institution of Janbernd Kirschner has received research support from Novartis.
Sitong Chen, Other Ms. Chen has nothing to disclose.
Matt Danzi Matt Danzi has nothing to disclose.
Matthis Synofzik Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphayzme Pharmaceuticals. The institution of Matthis Synofzik has received research support from EJPRD.
Francesco Muntoni, MD Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Avexis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
Nazli Basak Nazli Basak has nothing to disclose.
Teresa M. Dunn, PhD The institution of Dr. Dunn has received research support from CDMRP. The institution of Dr. Dunn has received research support from NIH. The institution of Dr. Dunn has received research support from NSF.
Thorsten Hornemann Thorsten Hornemann has nothing to disclose.
Stephan Zuchner, MD, FAAN Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Carsten G. Bonnemann, MD Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with RYR1 Foundation that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Genethon that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Sarepta Therapeutics that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with Kate Therapeutics that is relevant to AAN interests or activities. Dr. Bonnemann has a non-compensated relationship as a Scientific Advisor with CureCMD that is relevant to AAN interests or activities.
Irene Ossola No disclosure on file
Bilal Berke Ayvaz, MD Dr. Ayvaz has nothing to disclose.
Sema Saltik No disclosure on file
Fitnat Ulug No disclosure on file
Serhat Guler No disclosure on file
Anna Lo Presti No disclosure on file
Meghan McAnally, MD Dr. McAnally has nothing to disclose.
Abigail Potticary, Other Miss Potticary has nothing to disclose.
Ying Hu, Other Ms. Hu has nothing to disclose.
Laryssa Huryn, MD Dr. Huryn has nothing to disclose.
Lynn Pais, Other Miss Pais has nothing to disclose.
Keely Reidelberger No disclosure on file
Amanda Cyntia Lima Fonseca Rodrigues Ms. Rodrigues has nothing to disclose.
Alexander James Fay, MD, PhD Dr. Fay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Retrotope. Dr. Fay has received personal compensation in the range of $0-$499 for serving as a Consultant for Teladoc. Dr. Fay has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeglea. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Fay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curry Rockefeller Group. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspiro. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dwyer Hernandez. Dr. Fay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gallagher Bassett. Dr. Fay has received research support from Sarepta. The institution of Dr. Fay has received research support from Preston-Werner Ventures.
Jonathan B. Strober, MD Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Strober has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. Dr. Strober has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Many Law Firms. The institution of Dr. Strober has received research support from Anonymous. The institution of Dr. Strober has received research support from PTC. The institution of Dr. Strober has received research support from Fibrogen. The institution of Dr. Strober has received research support from Jansen. The institution of Dr. Strober has received research support from Biohaven.
Dhanalakshmi Angappan, MD Dr. Angappan has nothing to disclose.
Erika L. Finanger, MD Dr. Finanger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics. Dr. Finanger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Finanger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Finanger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Helen Mejia Santana No disclosure on file
Mark Stahl, MD, PhD Dr. Stahl has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Stahl has stock in Avidity Biosciences.
Elizabeth Jane Ackermann, PhD Dr. Ackermann has received personal compensation for serving as an employee of Avidity Biosciences.
Yiming Zhu, PhD Dr. Zhu has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Zhu has stock in Avidity Biosciences.
Steven G. Hughes Steven G. Hughes has received personal compensation for serving as an employee of Avidity Biosciences. Steven G. Hughes has received personal compensation for serving as an employee of Arcturus Therapeutics. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Ionis Pharmaceuticals. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Arcturus Therapeutics. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avidity Biosciences. Steven G. Hughes has stock in Arcturus Therapeutics. Steven G. Hughes has stock in Avidity Biosciences.
Yvonne Tami Ms. Tami has stock in Ionis Pharmaceuticals. Ms. Tami has stock in Avidity Biosciences.
Chamindra G. Laverty, MD Dr. Konersman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Konersman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Konersman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Konersman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Konersman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech/Roche. The institution of Dr. Konersman has received research support from Sarepta. The institution of Dr. Konersman has received research support from Novartis Gene Therapies. The institution of Dr. Konersman has received research support from Italfarmaco. The institution of Dr. Konersman has received research support from Fibrogen.
Craig McDonald, MD Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. McDonald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Capricor Therapeutics. Dr. McDonald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catabasis. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epirium Bio. Dr. McDonald has received personal compensation in the range of $0-$499 for serving as a Consultant for Italfarmaco. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Santhera Pharmaceuticals. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis Pharmaceuticals. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera Pharmaceuticals. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Santhera Pharmaceuticals. The institution of Dr. McDonald has received research support from Astellas. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Catabasis. The institution of Dr. McDonald has received research support from Epirium Bio. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from Pfizer. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from NIDILRR. The institution of Dr. McDonald has received research support from Department of Defense. The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Man Mohan Mehndiratta, MD, MBBS, FAAN Dr. Mehndiratta has nothing to disclose.
Harry William Sutherland, MD Dr. Sutherland has received personal compensation in the range of $0-$499 for serving as a Consultant for McGraw-Hill.
Jeremy Moeller, MD, FAAN Dr. Moeller has received publishing royalties from a publication relating to health care.
Sara Maguire Schaefer, MD, FAAN Dr. Schaefer has received personal compensation in the range of $0-$499 for serving as a Consultant for Qessential medical market research. Dr. Schaefer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cahill and perry .
Joseph Benes, MD Dr. Benes has nothing to disclose.
Isha Snehal, MBBS Dr. Snehal has nothing to disclose.
Subin Mathew, MD Dr. Mathew has nothing to disclose.
Daryl R. Gress, MD, FAAN Dr. Gress has nothing to disclose.
Makayla Schissel, Other Miss Schissel has nothing to disclose.
Sanjay Pandey, MD No disclosure on file
Cindy Ho Ms. Ho has nothing to disclose.
Dara V. Albert, DO, FAAN Dr. Albert has nothing to disclose.
Pedro Weisleder, MD, PhD Dr. Weisleder has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier .
Margie A. Ream, MD, PhD, FAAN Dr. Ream has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebird Bio. Dr. Ream has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for United Council for Neurologic Subspecialties. Dr. Ream has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Rushton, Stakely, Johnston & Garrett, P.A. . Dr. Ream has received personal compensation in the range of $10,000-$49,999 for serving as a Evidence Review Group member with Health Resources and Services Administration. Dr. Ream has received personal compensation in the range of $0-$499 for serving as a Organizational representative with Child Neurology Society.
Ajay Sharma No disclosure on file
Alana Jessica Kosches Ms. Kosches has nothing to disclose.
Kiara Stanifer, Other Miss Stanifer has nothing to disclose.
Nuri Jacoby, MD, FAAN Dr. Jacoby has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for N/A.
Archana Thakur No disclosure on file
Jessica Sanders, MD The institution of Dr. Sanders has received research support from Autism Intervention Research Network on Physical Health. The institution of Dr. Sanders has received research support from Accreditation Council for Graduate Medical Education.
Ashley Dafoe, Other Miss Dafoe has nothing to disclose.
Brooke Dorsey Holliman Brooke Dorsey Holliman has nothing to disclose.
Austin Michael Saline, MD Dr. Saline has nothing to disclose.
Varun Pandya, MD Dr. Pandya has nothing to disclose.
Ketevan Amirkhanashvili, MD Dr. Amirkhanashvili has nothing to disclose.
Sally Ladsaria, MD Dr. Ladsaria has nothing to disclose.
Thomas Draper, MD Dr. Draper has nothing to disclose.
Liane E. Hunter, MD, PhD Dr. Hunter has nothing to disclose.
Lauren Gluck, MD Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen.
Mark Milstein, MD, FAAN Dr. Milstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Milstein has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Milstein has received publishing royalties from a publication relating to health care. Dr. Milstein has a non-compensated relationship as a Board of Directors with New York County Medical Society that is relevant to AAN interests or activities.
Prachi Mehndiratta, MD Dr. Mehndiratta has nothing to disclose.
Samantha McMahon, DO Dr. McMahon has nothing to disclose.
Lauren Koffman, DO, MS Dr. Koffman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Law Firm.
Louis Goodrich, DO Dr. Goodrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono.
Ching Tsao, MD Dr. Tsao has nothing to disclose.
Natasha Gulati No disclosure on file
Lauren Bojarski, DO Dr. Bojarski has nothing to disclose.
Timothy James Ainger, PhD Dr. Ainger has nothing to disclose.
David Tate No disclosure on file
Syed Muhammad Owais Mr. Owais has nothing to disclose.
Fahham Asghar, MD Mr. Asghar has nothing to disclose.
Hira Pervez, MD, MBBS Dr. Pervez has nothing to disclose.
Sidra Saleem, MD Dr. Saleem has nothing to disclose.
Ajaz Sheikh, MD Dr. Sheikh has nothing to disclose.
Naeem Mahfooz, MD Dr. Mahfooz has nothing to disclose.
Joyeta Razzaque, MBBS Dr. Razzaque has nothing to disclose.
Rabia Zubair, MD Dr. Zubair has nothing to disclose.
Bashar Saour, MD Dr. Saour has nothing to disclose.
Anum Hamid Riaz, MD Dr. Riaz has nothing to disclose.
Imran I. Ali, MD, FAAN Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Sumayya Naz, MD Dr. Naz has nothing to disclose.
Kent McDonald No disclosure on file
R Edward Faught, Jr., MD, FAAN Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma.
Wesley Kerr, MD, PhD Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EpiTel. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from American Academy of Neurology. Dr. Kerr has received publishing royalties from a publication relating to health care.
Emily Klatte, MD Dr. Klatte has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuropace. Dr. Klatte has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis.
Clarence Wade Mr. Wade has received personal compensation for serving as an employee of SK Life Science, Inc..
Sean Stern Mr. Stern has received personal compensation for serving as an employee of SK Life Science.
Joe Wood No disclosure on file
Maryam Jamil Syed, MBBS Dr. Syed has nothing to disclose.
Jeongyeon Hwang, MD Dr. Hwang has nothing to disclose.
Deepti Zutshi, MD, FAAN Dr. Zutshi has nothing to disclose.
Rohit Ajay Marawar, MD, FAAN Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. The institution of Dr. Marawar has received research support from Catalyst Pharma.
Paul Sherman No disclosure on file
Peter Kochunov No disclosure on file
Kaylie Kaneshiro Miss Kaneshiro has nothing to disclose.
Keith Sueo Yamamoto Dr. Yamamoto has nothing to disclose.
Liza Rooks Ms. Rooks has nothing to disclose.
Johanna Mandl Ms. Mandl has nothing to disclose.
Enrique Carrazana Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurelis, Alexza, Zogenix. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences. Enrique Carrazana has stock in Neurelis, Marinus, .
Julia Roshan Jahansooz Miss Jahansooz has nothing to disclose.
Stephen A. McGuire, MD, FAAN No disclosure on file
Christina Rose Kyrtsos Catherine, MD Dr. Catherine has nothing to disclose.
Janet F. Waters, MD, FAAN An immediate family member of Dr. Waters has received personal compensation for serving as an employee of Haemonetics. An immediate family member of Dr. Waters has received personal compensation for serving as an employee of Vitalant. An immediate family member of Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haemonetics. An immediate family member of Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vitalant. An immediate family member of Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Vitalant. An immediate family member of Dr. Waters has received publishing royalties from a publication relating to health care.
Alexandra Urban, MD, FAAN Dr. Urban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Urban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science, Inc.
Philion Gatchoff, MD Dr. Gatchoff has nothing to disclose.
Ahmad Al-Awwad, MD Dr. Al-Awwad has nothing to disclose.
Estevao Pereira Ribeiro, MD Dr. Ribeiro has nothing to disclose.
Evan Fields, MD Dr. Fields has nothing to disclose.
Monika Michalec No disclosure on file
Anna Serafini, MD Dr. Serafini has nothing to disclose.
Elizabeth Cunningham Elizabeth Bachman has nothing to disclose.
Alexa Moriah King, MD Dr. King has received research support from American Neurologic Association. The institution of Dr. King has received research support from Esai Pharmaceuticals.
Elizabeth Gerard, MD Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of an immediate family member of Dr. Gerard has received research support from Novo Nordisk. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University).
Assia Meziane-Tani, MD No disclosure on file
Alexandra Moise, MD Dr. Moise has nothing to disclose.
Parisa Hassanzadeh, MD Dr. Hassanzadeh has nothing to disclose.
Kelly Rios Ms. Rios has nothing to disclose.
Anumeha Sharma Sheth, MBBS Dr. Sheth has nothing to disclose.
Sarah Lindsay, MD Dr. Lindsay has nothing to disclose.
Andrew G. Herzog, MD, MSc, FAAN Dr. Herzog has nothing to disclose.
Piero Perucca, MD The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi. The institution of Dr. Perucca has received research support from NHMRC. The institution of Dr. Perucca has received research support from Epilepsy Foundation. The institution of Dr. Perucca has received research support from Royal Australasian College of Physicians. The institution of Dr. Perucca has received research support from Melbourne Health. The institution of Dr. Perucca has received research support from Monash University. The institution of Dr. Perucca has received research support from Epilepsy Foundation . The institution of Dr. Perucca has received research support from Victorian Medical Research Acceleration Fund. The institution of Dr. Perucca has received research support from Sanming Project Grant, Shenzhen government. The institution of Dr. Perucca has received research support from Brain Australia. The institution of Dr. Perucca has received research support from Medical Research Future Fund. The institution of Dr. Perucca has received research support from Weary Dunlop Medical Research Foundation. The institution of Dr. Perucca has received research support from Norman Beischer Medical Research Foundation. The institution of Dr. Perucca has received research support from NHMRC. The institution of Dr. Perucca has received research support from Austin Medical Research Foundation.
Dimitrios Bourikas Dr. Bourikas has nothing to disclose.
Paula Emanuela Voinescu, MD The institution of Dr. Voinescu has received research support from Epilepsy Foundation of New England. The institution of Dr. Voinescu has received research support from BWH - Connors Center. The institution of an immediate family member of Dr. Voinescu has received research support from American Epilepsy Society. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Physicians' Education Resouce. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Phillipines League Against Epilepsy. Dr. Voinescu has a non-compensated relationship as a Board Member and Chair with My Epilepsy Story that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Speaker with Epilepsy Foundation that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with Epilepsy Ireland that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Member of Scientific Advisory Committee with North American AED Pregnancy Registry that is relevant to AAN interests or activities.
Lata Vadlamudi, MD, MBBS The institution of Dr. Vadlamudi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Vadlamudi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Daya Chellun Daya Chellun has nothing to disclose.
Thomas Kumke Thomas Kumke has nothing to disclose.
Konrad Werhahn Konrad Werhahn has received personal compensation for serving as an employee of UCB Pharma. Konrad Werhahn has stock in UCB Pharma.
Bettina *Use 388872 Schmitz No disclosure on file
Wendy Jiang No disclosure on file
Tyler Elyse Gaston, MD Dr. Gaston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Gaston has received research support from NINDS.
Hrishikesh Dadhich, MD Dr. Dadhich has nothing to disclose.
Pam Factor-Litvak Pam Factor-Litvak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ICF. Pam Factor-Litvak has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Publishing. The institution of Pam Factor-Litvak has received research support from NIH.
Diosely Castro Silveira, MD, PhD Dr. Silveira has nothing to disclose.
Abram Wahba, MD Dr. Wahba has nothing to disclose.
Michelle H. Lucena, MD Dr. Lucena has nothing to disclose.
Michelle Ganat, MD Dr. Ganat has nothing to disclose.
Raquel Romero, MD Dr. Romero has nothing to disclose.
Wei Zheng No disclosure on file
Ioannis Karakis, MD, FAAN Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.
Santiago Flesler Santiago Flesler has nothing to disclose.
Meng Han Tsai, MD Dr. Tsai has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Tsai has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. Dr. Tsai has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for GSK. The institution of Dr. Tsai has received research support from National Heath Research Institute. The institution of Dr. Tsai has received research support from National Science Technology Council.
Ovi Sanman Ghorpade, MD Dr. Ghorpade has received personal compensation for serving as an employee of GSK. Dr. Ghorpade has stock in GSK.
Rio Carla Pineda, MD Dr. Pineda has received personal compensation for serving as an employee of GSK. Dr. Pineda has stock in GSK.
Kalpesh Joshi, MD Dr. Joshi has received personal compensation for serving as an employee of GSK. Dr. Joshi has stock in GSK.
James Cooper, PhD Dr. Cooper has received personal compensation for serving as an employee of GSK. Dr. Cooper has stock in GSK.
SHILPA PATKAR, Other Miss PATKAR has stock in GSK.
Andrea Schulz, Other Mrs. Schulz has nothing to disclose.
Savita Bakhshi Anand, PhD Dr. Anand has nothing to disclose.
Nicola Barnes Ms. Barnes has received personal compensation for serving as an employee of Evidera.
Galeno Rojas, MD No disclosure on file
Julia Reedy, Other Ms. Reedy has nothing to disclose.
Teneille Gofton, MD The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Margaret Gopaul, PhD Dr. Gopaul has nothing to disclose.
Raquel Farias-Moeller, MD Dr. Farias-Moeller has nothing to disclose.
Marissa Kellogg, MD, MPH Dr. Kellogg has nothing to disclose.
Lawrence J. Hirsch, MD, FAAN Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accure. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rafa Laboratories, Ltd. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a speaker with UCB.
Nora Wong, PhD Ms. Wong has nothing to disclose.
Krista L. Eschbach, MD The institution of Dr. Eschbach has received research support from Neurocrine Biosciences. The institution of Dr. Eschbach has received research support from UCB Biopharma. The institution of Dr. Eschbach has received research support from Pediatric Epilepsy Research Foundation. Dr. Eschbach has a non-compensated relationship as a Medical Science Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Adriana Leis No disclosure on file
Satish *USE ID 130692 Rao, MD Dr. Rao has received personal compensation for serving as an employee of Takeda Pharmaceuticals USA, Inc.. Dr. Rao has stock in Takeda Pharmaceuticals USA, Inc..
David Iwanyckyj Mr. Iwanyckyj has received personal compensation for serving as an employee of Amplity Health.
Pablo Racana, Other Mr. Racana has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amplity Health.
Fernando Damian Otalora Mr. Otalora has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amplity Health.
Mei Lu Ms. Lu has received personal compensation for serving as an employee of Takeda Pharmaceuticals USA Inc.. Ms. Lu has stock in Takeda Pharmaceuticals USA, Inc..
Sally W. Wade, Other The institution of Ms. Wade has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Abbvie. The institution of Ms. Wade has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for J&J. The institution of Ms. Wade has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Kite Pharma.
Hilal Tastekin Toz No disclosure on file
Lobna Ahmed Mohammed Abdelwahab, MD Dr. Abdelwahab has nothing to disclose.
Jaahnavee Trivedi, MD Dr. Trivedi has nothing to disclose.
Aditya Chanpura Mr. Chanpura has nothing to disclose.
Yaacov Anziska, MD Dr. Anziska has nothing to disclose.
Feride Un Candan No disclosure on file
Angus Lee, DO Dr. Lee has nothing to disclose.
Jessica Betty Smith, MPH Ms. Smith has nothing to disclose.
Bonnie Li Bonnie Li has nothing to disclose.
Radostina Iordanova, DO Dr. Iordanova has nothing to disclose.
Annette M. Langer-Gould, MD, PhD An immediate family member of Dr. Langer-Gould has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of American Thoracic Society. The institution of Dr. Langer-Gould has received research support from PCORI. The institution of an immediate family member of Dr. Langer-Gould has received research support from PCORI, ARQ, NIH. Dr. Langer-Gould has a non-compensated relationship as a Voting Member with ICER CTAF Panel that is relevant to AAN interests or activities.
Aysun Soysal, MD Dr. Soysal has nothing to disclose.
Joshua Thomas Blotter, MD Dr. Blotter has nothing to disclose.
Jau-Shin Lou, MD, PhD, FAAN Dr. Lou has nothing to disclose.
Duygu Aksoy No disclosure on file
Martin Stangel, MD Prof. Stangel has received personal compensation for serving as an employee of Novartis. Prof. Stangel has stock in Novartis. Prof. Stangel has received publishing royalties from a publication relating to health care.
Dominik Feuerbach, PhD Dr. Feuerbach has received personal compensation for serving as an employee of Novartis . Dr. Feuerbach has stock in Novartis. Dr. Feuerbach has received intellectual property interests from a discovery or technology relating to health care.
Derya Shimshek Derya Shimshek has received personal compensation for serving as an employee of Novartis Pharma AG. Derya Shimshek has stock in Novartis Pharma AG. Derya Shimshek has received intellectual property interests from a discovery or technology relating to health care.
Fabrizio Gasparini Dr. Gasparini has received personal compensation for serving as an employee of Novartis. Dr. Gasparini has stock in Novartis.
Ivan Galimberti, PhD Dr. Galimberti has received personal compensation for serving as an employee of Novartis. Dr. Galimberti has stock in Novartis.
Nathalie George, PhD Mrs. George has received personal compensation for serving as an employee of Novartis Pharma AG. Mrs. George has stock in Novartis Pharma AG. Mrs. George has received intellectual property interests from a discovery or technology relating to health care.
Gisela Peraus, PhD Dr. Peraus has received personal compensation for serving as an employee of Novartis. Dr. Peraus has stock in Novartis. An immediate family member of Dr. Peraus has received intellectual property interests from a discovery or technology relating to health care.
Judit Sovago, MD,PhD Dr. Sovago has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Sovago has stock in Novartis Pharma AG.
Nilufer Kale, MD Dr. Kale has nothing to disclose.
Aaron M. Carlson, MD Dr. Carlson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Carlson has received research support from Horizon Therapeutics. Dr. Carlson has a non-compensated relationship as a Health Service Subcommittee Member with American Academy of Neurology that is relevant to AAN interests or activities.
Daniel Pastula, MD, MHS, FAAN Dr. Pastula has nothing to disclose.
Rumyar Vojdanian Ardakani, MD Dr. Ardakani has nothing to disclose.
Sarah Kelly, PA Ms. Kelly has nothing to disclose.
Sarah Guistolisi, MD Dr. Guistolisi has nothing to disclose.
Dilek Atakli No disclosure on file
Helena Huhmar Helena Huhmar has nothing to disclose.
Olli Juhani Polo, MD,PhD Dr. Polo has nothing to disclose.
Lauri Sakari Soinne, MD, PhD Dr. Soinne has nothing to disclose.
Per Sjögren, Other The institution of Prof. Sjögren has received research support from Patient-led Research Collaboration, US. Prof. Sjögren has received publishing royalties from a publication relating to health care.
Bo Christer Bertilson, MD,PhD The institution of Dr. Bertilson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medect Clinical Trial AB. The institution of Dr. Bertilson has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medect Clinical Trials AB. The institution of Dr. Bertilson has received research support from ME UK. Dr. Bertilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Bertilson has received personal compensation in the range of $500-$4,999 for serving as a teacher with Region Stockholm.
Björn Bragée, MD Dr. Bragée has nothing to disclose.
Per Hamid Ghatan, MD Dr. Ghatan has nothing to disclose.
Talha Ahmad Mr. Ahmad has nothing to disclose.
Sam Hooshmand, DO Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech/Roche. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Erie Gonzalez Gutierrez, MD Dr. Gonzalez Gutierrez has nothing to disclose.
Andrea Stahulak, MD Dr. Stahulak has nothing to disclose.
B. Parsons No disclosure on file
Lydia Kauffman, MD Dr. Kauffman has nothing to disclose.
Nader El Seblani, MD, PhD Dr. El Seblani has nothing to disclose.
James Grogan, MD Dr. Grogan has nothing to disclose.
Jikku Jose Zachariah, DO Dr. Zachariah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS, Sanofi.
Rae E. Bacharach, DO Dr. Bacharach has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology.
Puneet Singh Kochar Dr. Kochar has nothing to disclose.
Birol Emir, PhD No disclosure on file
Jennifer Lauren Orthmann Murphy, MD, PhD Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for Vigil Neuroscience. Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for NovoGlia. The institution of Dr. Orthmann Murphy has received research support from Vigil Neurosciences. The institution of Dr. Orthmann Murphy has received research support from National MS Society. The institution of Dr. Orthmann Murphy has received research support from Fishman Family Foundation. The institution of Dr. Orthmann Murphy has received research support from Global Leukodystrophy Initiative Clinical Trial Network. Dr. Orthmann Murphy has received personal compensation in the range of $500-$4,999 for serving as a Developing CME content on Neurogenetics with American Neurological Association.
Malya Sahu, MD Dr. Sahu has nothing to disclose.
Natalie Rachel Schanzer Ms. Schanzer has nothing to disclose.
Matthew Menken, MD, FACP, FAAN No disclosure on file
Gabriela Alejandra Bou, MD Dr. Bou has nothing to disclose.
Adam Goldman-Yassen, MD Dr. Goldman-Yassen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Miller Weisbrod Olesky LLP. The institution of Dr. Goldman-Yassen has received research support from NIH.
Morgan E. Morris, Other Miss Morris has nothing to disclose.
Monideep Dutt, MD Dr. Dutt has nothing to disclose.
Phaethon Philbrook, PhD Dr. Philbrook has received intellectual property interests from a discovery or technology relating to health care.
Grace Gombolay, MD Dr. Gombolay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. An immediate family member of Dr. Gombolay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Washington Injury Lawyers. The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH.
Lindsay Rechtman The institution of Lindsay Rechtman has received research support from ATSDR.
Rana Usman Anwar, MD,MBBS Dr. Anwar has nothing to disclose.
Muhammad Ismail Khalid Yousaf, MD Dr. Yousaf has nothing to disclose.
Victoria Nicole Holiday, MD Dr. Holiday has nothing to disclose.
Martin E Brown, MD Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Brown has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Brown has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with University of Louisville.
Mohammad Ravi Ghani, MD Dr. Ghani has nothing to disclose.
Heather Sevinsky, Other Ms. Sevinsky has received personal compensation for serving as an employee of Biohaven. Ms. Sevinsky has stock in Biohaven.
Bharat Awsare, MD Dr. Awsare has received personal compensation for serving as an employee of Biohaven. Dr. Awsare has stock in Biohaven.
Rachel Rozakis, Other Dr. Rozakis has nothing to disclose.
Kimberly Gentile Kimberly Gentile has stock in Biohaven.
Patricia Mydlow Ms. Mydlow has nothing to disclose.
Eric Ashbrenner Mr. Ashbrenner has received personal compensation for serving as an employee of Biohaven. Mr. Ashbrenner has received personal compensation for serving as an employee of Navitas. Mr. Ashbrenner has stock in Biohaven. An immediate family member of Mr. Ashbrenner has stock in Biohaven.
Rachel Ham, Other Ms. Ham has received personal compensation for serving as an employee of Allucent.
David Stock David Stock has received personal compensation for serving as an employee of Biohaven . David Stock has stock in Biohaven .
Irfan Qureshi, MD Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Vladimir Coric Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Richard Bertz Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.
Laurie Wagner Laurie Wagner has nothing to disclose.
Melissa Beiner Melissa Beiner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Melissa Beiner has stock in Biohaven Pharmaceuticals.
Stephen Kaplita Mr. Kaplita has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Mr. Kaplita has stock in Biohaven Pharmaceuticals.
Rong Yang, PhD Dr. Yang has received personal compensation for serving as an employee of Biohaven Pharmaceutical. Dr. Yang has stock in Biohaven Pharmaceutical.
Azim Munivar, MD Dr. Munivar has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Victoria Wirtz Victoria Wirtz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Victoria Wirtz has stock in Biohaven Pharmaceuticals, Inc.
Mary Kathleen Donohue, Other Ms. Donohue has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc.. Ms. Donohue has stock in Biohaven Pharmaceuticals, Inc..
Betty K. Hussey, Other Dr. Hussey has received personal compensation for serving as an employee of Allucent.
Liang Lu, MD, FAAN Dr. Lu has nothing to disclose.
Andrew M. Blumenfeld, MD, FAAN Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck.
Laszlo Mechtler, MD, FAAN, FASN Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Jushi Inc. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Mechtler has received stock or an ownership interest from Jushi Co.. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Amgen/Novartis. The institution of Dr. Mechtler has received research support from Alder/ Lundbeck. The institution of Dr. Mechtler has received research support from Abbvie/Allergan. The institution of Dr. Mechtler has received research support from Miles for Migraine. The institution of Dr. Mechtler has received research support from American Migraine Foundation. The institution of Dr. Mechtler has received research support from Charlotte's Web.
Lisa *USE ID 138530 Cook, MD Dr. Cook has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Cook has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. The institution of Dr. Cook has received research support from Abbvie . The institution of Dr. Cook has received research support from Aeon. The institution of Dr. Cook has received research support from Axsome . The institution of Dr. Cook has received research support from Lilly .
Christopher P. Rhyne, MD Dr. Rhyne has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. Dr. Rhyne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie/Allergan. Dr. Rhyne has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie/Allergan. Dr. Rhyne has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Rhyne has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Rhyne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Rhyne has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly. Dr. Rhyne has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theranica. Dr. Rhyne has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Rhyne has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Diamond Headache Clinic Research and Education Foundation. Dr. Rhyne has received personal compensation in the range of $500-$4,999 for serving as a Speaker with National Headache Foundation.
Brian Jenkins, DO Dr. Jenkins has received personal compensation for serving as an employee of Abbvie. Dr. Jenkins has received personal compensation for serving as an employee of Allergan. Dr. Jenkins has received personal compensation for serving as an employee of Teva. Dr. Jenkins has received personal compensation for serving as an employee of Biohaven. Dr. Jenkins has received personal compensation for serving as an employee of Lundbeck . Dr. Jenkins has received personal compensation for serving as an employee of Amgen and Novartis. Dr. Jenkins has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Jenkins has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan . Dr. Jenkins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Jenkins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven . Dr. Jenkins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Dr. Jenkins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen and Novartis. Dr. Jenkins has stock in Prevacus. Dr. Jenkins has received intellectual property interests from a discovery or technology relating to health care.
Olivia Hughes, Other Ms. Hughes has received personal compensation for serving as an employee of ICON plc.
Brett Dabruzzo, PharmD Dr. Dabruzzo has received personal compensation for serving as an employee of AbbVie. Dr. Dabruzzo has stock in AbbVie.
Aubrey Adams, PhD Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Merle Diamond Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan/AbbVie . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck Pharmaceutical . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel NeuroPharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Promius. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/AbbVie. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Assertio. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Promius Pharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher-Smith . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel Neuro Pharma . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Assertio. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axsome Pharma . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Assertio Therapeutics . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Upsher Smith. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Impel Neuro Pharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan/AbbVie. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lundbeck . Merle Diamond has received research support from Amgen . Merle Diamond has received research support from Lundbeck. Merle Diamond has received research support from Teva . Merle Diamond has received research support from Eli Lilly. Merle Diamond has received research support from Allergan. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Course Directory, Speaker with Diamond Research & Educational Foundation.
Lei Zheng No disclosure on file
Andreas Straube Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. The institution of Andreas Straube has received research support from German research Counci (BMBF).
Gregor Broessner Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for TEVA. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Lilly. Gregor Broessner has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly.
Xenia Hamann, MD Dr. Hamann has received personal compensation for serving as an employee of Teva GmbH.
Charly Gaul Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Weber & Weber, Lundbeck, and Perfood. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan Pharma, Lilly, Novartis Pharma, Hormosan Pharma, Sanofi-Aventis, Perfood, and TEVA. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan Pharma, Lilly, Novartis Pharma, Hormosan Pharma, Grünenthal, Sanofi-Aventis, and TEVA. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Journal of Headache and Pain, Acta Neurologica Scandinavia. Dr. Gaul has received publishing royalties from a publication relating to health care. Dr. Gaul has received personal compensation in the range of $0-$499 for serving as a Honorary secretary with German Migraine and Headache Society.
Torsten Kraya, MD Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA, Novartis, Lilly. Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA, Novartis, Lilly, Hormosan, Abbvie.
Lars Oliver Neeb Neeb Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Neeb has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Neeb has received research support from Teva. The institution of Dr. Neeb has received research support from Eli Lilly.
Ying Si No disclosure on file
Sarah Cotton Sarah Cotton has nothing to disclose.
Lucy Natasha Hancock Miss Hancock has nothing to disclose.
James Jackson James Jackson has nothing to disclose.
William Alfred Whitton Mr. Whitton has nothing to disclose.
Shin J. Oh, MD, FAAN No disclosure on file
Ariel Israel, MD,PhD Dr. Israel has nothing to disclose.
Shlomo Vinker, MD Prof. Vinker has nothing to disclose.
Danna Davidovici, Other Ms. Davidovici has received personal compensation for serving as an employee of Pfizer .
Matanya Tirosh Mr. Tirosh has received personal compensation for serving as an employee of Pfizer Pharmaceuticals Israel LTD.
Itay Fo, MD Dr. FO has nothing to disclose.
Erel Domany, MD Dr. Domany has nothing to disclose.
Alla Shifrin, MD Dr. Shifrin has nothing to disclose.
Peter H. King, MD The institution of Dr. King has received research support from Department of Veterans Affairs. The institution of Dr. King has received research support from NIH.
Charles E. Argoff, MD Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nevro. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for XGene. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Colllegium. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Argoff has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Scilex. The institution of Dr. Argoff has received research support from Lilly. The institution of Dr. Argoff has received research support from Lundbeck. The institution of Dr. Argoff has received research support from Abbvie. The institution of Dr. Argoff has received research support from Vertex. Dr. Argoff has received publishing royalties from a publication relating to health care.
Fawad A. Khan, MD The institution of Dr. Khan has received research support from Amgen .
Steven P. Herzog, MD Dr. Herzog has nothing to disclose.
Ryan M. Smith, DO, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Susanne Awad, PhD Dr. Awad has nothing to disclose.
Divya Asher Divya Asher has received personal compensation for serving as an employee of Lundbeck. Divya Asher has received personal compensation for serving as an employee of AbbVie.
Seema Soni-Brahmbhatt Seema Soni-Brahmbhatt has nothing to disclose.
Ahn Hee Seung No disclosure on file
Joachim Hipp, PhD Dr. Hipp has received personal compensation for serving as an employee of Teva.
Wi-Sun Ryu No disclosure on file
Christopher H. Hawkes, MD, Bsc, FRCP, FAAN Dr. Hawkes has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Pranav Gandhi Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Lauren Wilson, Other Ms. Wilson has nothing to disclose.
Sarah Ayton, PhD Dr. Ayton has nothing to disclose.
Kandavadivu Umashankar, Other Mrs. Umashankar has received personal compensation for serving as an employee of Abbvie.
Molly Duan, Other Ms. Duan has received personal compensation for serving as an employee of abbvie.
Jessica Ailani, MD, FAAN Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gore. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eneura. Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Report. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape. The institution of Dr. Ailani has received research support from Satsuma. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Medical Advisor with SELF.
David Boniface No disclosure on file
Carlyn Patterson Gentile, MD The institution of Dr. Patterson Gentile has received research support from American Academy of Neurology. The institution of Dr. Patterson Gentile has received research support from American Headache Society, American Migraine Foundation, Canadian Headache Society, International Headache Society. The institution of Dr. Patterson Gentile has received research support from NeuroNEXT NINDS. The institution of Dr. Patterson Gentile has received research support from NIH/NINDS. Dr. Patterson Gentile has received personal compensation in the range of $0-$499 for serving as a Faculty, Annual Scientific Meeting and Residency Education program with American Headache Society. Dr. Patterson Gentile has received personal compensation in the range of $500-$4,999 for serving as a Ad Hoc Grant Reviewer with Department of Defense. Dr. Patterson Gentile has received personal compensation in the range of $0-$499 for serving as a Ad Hoc Grant Reviewer with NIH/NIMH.
Christina *Use 153549 Szperka The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Szperka has received research support from Pfizer. Dr. Szperka has received research support from FDA.
Christina Master, MD, FAAP, CAQSM The institution of Dr. Master has received research support from NIH. The institution of Dr. Master has received research support from DoD. The institution of Dr. Master has received research support from AMSSM. The institution of Dr. Master has received research support from PA Department of Health.
Caroline Gentile Kruse, MD Dr. Gentile Kruse has nothing to disclose.
Andrew D. Hershey, MD, PhD, FAHS, FAAN The institution of Dr. Hershey has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher-Smith. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Hershey has received research support from Amgen. The institution of Dr. Hershey has received research support from NIH, NINDS. The institution of Dr. Hershey has received research support from Bioahaven. The institution of Dr. Hershey has received research support from Upsher-Smith. Dr. Hershey has received publishing royalties from a publication relating to health care.
Blanca Marquez de Prado Blanca Marquez de Prado has nothing to disclose.
Nichelle Raj Nichelle Raj has nothing to disclose.
Morgan Evans, Other Miss Evans has nothing to disclose.
Pratishtha Panigrahi Ms. Panigrahi has nothing to disclose.
Soumyaa Das Miss Das has nothing to disclose.
Ryan Shah Mr. Shah has nothing to disclose.
John W. Norris, MD No disclosure on file
Thomas Finnegan, Jr., PhD Dr. Finnegan has nothing to disclose.
Katie Stringer Lucero Dr. Lucero has nothing to disclose.
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cleaview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Medical Comm. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Education Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' Education Resource. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical Education. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview.
Amaal J. Starling, MD, FAAN Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Med-IQ. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Everyday Health. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura.
Suzanne Szak No disclosure on file
Aaron Briggs, MD Dr. Briggs has nothing to disclose.
Joe Diego Family Risser, MD,NP Dr. Risser has nothing to disclose.
Andrea Dearth No disclosure on file
Joo Won Choi Mr. Choi has nothing to disclose.
Stacy C. Brown, MD Dr. Brown has nothing to disclose.
Kirsten Hyean Jin Ms. Jin has nothing to disclose.
Normand E. Allaire No disclosure on file
Abdelrahman Essam Ahmed Soliman Elfaham, MBBS Dr. Elfaham has nothing to disclose.
Lara Eltous, MBBS Dr. Eltous has nothing to disclose.
Ammar Abdulraheem Ah Jumah, MD Dr. Jumah has nothing to disclose.
Diego Cadavid, MD, FAAN Dr. Cadavid has received personal compensation for serving as an employee of X4 Pharma. Dr. Cadavid has received personal compensation for serving as an employee of Fulcrum Therapeutics. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvinas. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata Therapeutics. Dr. Cadavid has received stock or an ownership interest from X4 Pharma. Dr. Cadavid has received stock or an ownership interest from Fulcrum Therapeutics.
Lokesh Saini, DM Dr. Saini has nothing to disclose.
Sujatha Manjunathan, MD Dr. Manjunathan has nothing to disclose.
Pradeep Kumar Gunasekaran Pradeep Kumar Gunasekaran has nothing to disclose.
Prawin Kumar, MD Dr. KUMAR has nothing to disclose.
Jagdish Prasad Goyal, MD Dr. Goyal has nothing to disclose.
Sarbesh Tiwari Sarbesh Tiwari has nothing to disclose.
Bharat Choudhary, MD Dr. Choudhary has nothing to disclose.
Robert Simpson No disclosure on file
Melanie Li, MD Dr. Li has nothing to disclose.
Raissa Aoun, MD Dr. Aoun has nothing to disclose.
Rebecca Lalchan, DO Dr. Lalchan has nothing to disclose.
Sylvia A Mohen, MD No disclosure on file
Nithisha Prasad, MD Miss Prasad has nothing to disclose.
Scott Grossman, MD Dr. Grossman has nothing to disclose.
Benjamin Brush, MD Dr. Brush has nothing to disclose.
Eddie Louie Eddie Louie has nothing to disclose.
Donato *use 298793 Pacione, MD Dr. Pacione has nothing to disclose.
Samantha Smalley, Other Dr. Smalley has nothing to disclose.
Ariane Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Kara R. Melmed, MD Dr. Melmed has nothing to disclose.
Lenore C. Ocava, MD No disclosure on file
Manasvi Gupta Miss Gupta has nothing to disclose.
Ahmad Faraz, MD Dr. Faraz has nothing to disclose.
Nafees Ahmad Khan, MD Dr. Khan has nothing to disclose.
Meenakshi Gupta, MD No disclosure on file
Nathalie Guy Renouil, MD No disclosure on file
Shanindra Revanka De Alwis, MD, MBBS Dr. De Alwis has nothing to disclose.
Bimsara Senanayake, MBBS, MD, FRCP No disclosure on file
Anuradha Jayakody, MD Dr. Jayakody has nothing to disclose.
Beatrice Claise No disclosure on file
Mohammad Hani Mohammad Almomani, MD Dr. Almomani has nothing to disclose.
Camila Narvaez Caicedo, MD Dr. Narvaez Caicedo has nothing to disclose.
Chilvana V. Patel, MBBS, FAAN Dr. Patel has nothing to disclose.
Lajja Nishith Majmundar Ms. Majmundar has nothing to disclose.
Sepideh F. Varon No disclosure on file
Capucine Piat Dr. Piat has nothing to disclose.
Aidan Mullan Aidan Mullan has nothing to disclose.
Rodolfo Savica, MD, PhD, FAAN The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Khaled Ghoniem, MD Dr. Ghoniem has nothing to disclose.
Pierpaolo Turcano, MD Dr. Turcano has nothing to disclose.
Adil Bharucha Adil Bharucha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Evoke Pharma. Adil Bharucha has stock in several companies NOT in the healthcare sector. The institution of Adil Bharucha has received research support from Minnesota Medical Technologies. The institution of Adil Bharucha has received research support from Michael J Fox Foundation. Adil Bharucha has received intellectual property interests from a discovery or technology relating to health care. Adil Bharucha has received intellectual property interests from a discovery or technology relating to health care. Adil Bharucha has received intellectual property interests from a discovery or technology relating to health care.
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Eduardo E. Benarroch, MD, FAAN Dr. Benarroch has nothing to disclose.
Patrick J. Gillard, PharmD, MS Mr. Gillard has received personal compensation for serving as an employee of AbbVie. Mr. Gillard has stock in AbbVie.
Omolara Lawal, MD Dr. Lawal has nothing to disclose.
Lisa M. Shulman, MD, FAAN The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Stephen G. Reich, MD, FAAN Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Reich has received research support from ninds. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Ann L. Gruber-Baldini The institution of Ann L. Gruber-Baldini has received research support from NIH. The institution of Ann L. Gruber-Baldini has received research support from Gilead Foundation. Ann L. Gruber-Baldini has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with NIH.
Melissa Annette Morales Garcia, MD Dr. Morales Garcia has nothing to disclose.
Joseph M. Savitt, MD, PhD The institution of Dr. Savitt has received research support from NIH. The institution of Dr. Savitt has received research support from Biogen. The institution of Dr. Savitt has received research support from Roche. The institution of Dr. Savitt has received research support from Neuraly. The institution of Dr. Savitt has received research support from Neuroderm. The institution of Dr. Savitt has received research support from Insightec.
Sunita Shakya, PhD Dr. Shakya has nothing to disclose.
F. Rainer Von Coelln, MD The institution of Dr. Von Coelln has received research support from University of Maryland and Maryland State Goverment. Dr. Von Coelln has received intellectual property interests from a discovery or technology relating to health care.
Ryan Hansen No disclosure on file
Motohiro Okumura, MD Dr. Okumura has nothing to disclose.
Youhei Mukai, MD Dr. Mukai has nothing to disclose.
Reiko Saika, MD,PhD Dr. Saika has nothing to disclose.
Yuji Takahashi, MD, PhD The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Emily Devine No disclosure on file
James Searson Mr. Searson has nothing to disclose.
Octavian R. Adam, MD The institution of Dr. Adam has received research support from Jazz Pharmaceutical. The institution of Dr. Adam has received research support from Sage Therapeutics. The institution of Dr. Adam has received research support from Abbott Laboratories.
Jessica Helena Goldstein, MD, FAAN Dr. Goldstein has nothing to disclose.
Tila Warner-Rosen Ms. Warner-Rosen has nothing to disclose.
Christopher Goetz, MD, FAAN The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Michelle HS Tosin, PhD, RN Dr. Tosin has nothing to disclose.
David Andres Gonzalez Mr. Gonzalez has nothing to disclose.
Bilal Zonjy No disclosure on file
Irma Zhang Ms. Zhang has nothing to disclose.
Fernando L. Pagan, MD Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Michelle Umali, Other Ms. Umali has nothing to disclose.
Luke Dantzler Lovelace, Other Mr. Lovelace has nothing to disclose.
Michael Patrick Barry, PhD The institution of Dr. Barry has received research support from National Institutes of Health. Dr. Barry has received intellectual property interests from a discovery or technology relating to health care.
Lina Maria Ariza Serrano, MD Dr. Ariza Serrano has nothing to disclose.
Gonul Dursun Ozay, MD Dr. Ozay has nothing to disclose.
Alexandre Mason Sharma, MD Dr. Mason Sharma has nothing to disclose.
Lana W. Raslan, Other Ms. Raslan has nothing to disclose.
Yasar Alejandro Torres-Yaghi, MD Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Yaghi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion .
Ingrid E. Tuxhorn, MD No disclosure on file
Esther Cubo Delgado, MD, FAAN Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Florita Valiñas Florita Valiñas has nothing to disclose.
Marta Allende Del Río Marta Allende Del Río has nothing to disclose.
Alvar Arnaiz-Gonzalez, PhD Dr. Arnaiz-Gonzalez has nothing to disclose.
José Francisco Diez Pastor, Other Dr. Diez Pastor has nothing to disclose.
Alicia Olivares Gil Mrs. Olivares Gil has nothing to disclose.
José Miguel Ramírez Sanz José Miguel Ramírez Sanz has nothing to disclose.
Alvaro Garcia Bustillo Alvaro Garcia Bustillo has nothing to disclose.
Barbara Bangert No disclosure on file
Matthew J. Barrett, MD Dr. Barrett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare LLC. The institution of Dr. Barrett has received research support from Kyowa Kirin. The institution of Dr. Barrett has received research support from NIH.
Ahmed Said Negida, MD, PhD Dr. Negida has nothing to disclose.
Sarah Kathryn Lageman, PhD Dr. Lageman has nothing to disclose.
Brian D. Berman, MD, MS, FAAN Dr. Berman has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for International Parkinson and Movement Disorder Society. The institution of Dr. Berman has received research support from Dystonia Medical Research Foundation. The institution of Dr. Berman has received research support from Administration for Community Living. The institution of Dr. Berman has received research support from The Parkinson Foundation. The institution of Dr. Berman has received research support from National Institutes of Health.
Aashish Batheja Mr. Batheja has nothing to disclose.
Nancy E. Bass, MD Dr. Bass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elseviert.
Cindy Marie Happel, RN Mrs. Happel has stock in Supernus Pharmaceutical.
Mindy Grall, PhD, NP Ms. Grall has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Ms. Grall has stock in Supernus.
Andrea Formella, PharmD, BCPP Dr. Formella has received personal compensation for serving as an employee of Adamas Pharmaceuticals, Inc. Dr. Formella has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc. Dr. Formella has stock in Adamas Pharmaceuticals. Dr. Formella has stock in Supernus Pharmaceuticals, Inc..
Eric Jackson No disclosure on file
Caroline M. Tanner, MD, PhD, FAAN Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Monica Korell, MPH Ms. Korell has nothing to disclose.
Meredith Bock, MD The institution of Dr. Bock has received research support from American Academy of Neurology. The institution of Dr. Bock has received research support from Michael J Fox Foundation.
Ethan G. Brown, MD Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH.
Julien Valverde Twiggs Julien Valverde Twiggs has nothing to disclose.
Betsy Hulme Ms. Hulme has nothing to disclose.
Brittany Contreras, Other Miss Contreras has nothing to disclose.
Kathleen Comyns Ms. Comyns has nothing to disclose.
Krista Lyn Harrison, PhD An immediate family member of Dr. Harrison has received personal compensation for serving as an employee of Mathematica Policy Research. The institution of Dr. Harrison has received research support from NIH/NIA; Michael J Fox Foundation.
Sagar Chawla No disclosure on file
Jori Fleisher, MD, MSCE, FAAN The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NIA/Emory Roybal Center for Dementia Caregiving Mastery. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Melani Dizon, Other Mrs. Dizon has received personal compensation for serving as an employee of Davis Phinney Foundation for Parkinson's. Mrs. Dizon has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Davis Phinney Foundation for Parkinson's.
Polly Dawkins Ms. Dawkins has received personal compensation for serving as an employee of Davis Phinney Foundation.
Christina Loporcaro No disclosure on file
Mateus Damiani Monteiro, MD Dr. Damiani Monteiro has nothing to disclose.
Carlos Rieder Carlos Rieder has nothing to disclose.
Arlete Hilbig, MD Arlete Hilbig, MD has nothing to disclose.
Liana Lisboa Fernandez, PhD,MD The institution of Prof. Fernandez has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Knight.
Euripedes Gomes De Carvalho Neto, MD Dr. Carvalho Neto has nothing to disclose.
Nicolas Contreras No disclosure on file
Zhao Wang, PhD Dr. Wang has nothing to disclose.
Roberto Gomeni, PhD The institution of Mr. Gomeni has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pharmacometrica.
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Global Kinetics Consulting (GKC). Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDerm. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion Neurostim LLC. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar Inc.. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus Pharma. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inhibikase. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pharma 2 B. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivifi Biotech. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ovid Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AgeX Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanex. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MDCE Suzhou. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PDNeurotechnology. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regenxbio. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tremor Research Support Group. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tris Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ameal . Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sunovion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Cerevel. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Inhibikase. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has stock in Inhibikase. Dr. Hauser has stock in Axial Therapeutics. Dr. Hauser has stock in Enterin. Dr. Hauser has stock in Revance Therapeutics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Artizan Biosciences. The institution of Dr. Hauser has received research support from Parkinsons & Movement Disorder Alliance. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Aeon Biopharma. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Bukwang Pharmaceutical Co., Ltd.. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Cynapsus Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Impax Labratories. The institution of Dr. Hauser has received research support from Integrative Research Labratories Sweden. The institution of Dr. Hauser has received research support from Lundbeck, Inc.. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuraly Inc.. The institution of Dr. Hauser has received research support from Neurocrine Biosciences. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Pharma Two B Ltd.. The institution of Dr. Hauser has received research support from Revance Therapeutics. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Sanofi Pharmaceuticals. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from SunPharma. The institution of Dr. Hauser has received research support from UCB BioPharma. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Rajesh Pahwa, MD, FAAN Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allevion. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Photopharmics. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sun Biopharma. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Biohaven. The institution of Dr. Pahwa has received research support from EIP. The institution of Dr. Pahwa has received research support from Amneal. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theranexus. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Voyager. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Annovis. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Praxis. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB.
Olivier Rascol, MD, PhD Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Asfiha Gebre Mr. Gebre has nothing to disclose.
Gianpiera Ceresoli-Borroni, PhD Dr. Ceresoli-Borroni has nothing to disclose.
Jonathan Rubin, MD Dr. Rubin has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Dr. Rubin has received stock or an ownership interest from Supernus Pharmaceuticals. Dr. Rubin has received stock or an ownership interest from Atentiv.
Nina F. Schor, MD, PhD, FAAN Dr. Schor has received publishing royalties from a publication relating to health care. Dr. Schor has received personal compensation in the range of $100,000-$499,999 for serving as a Deputy Director, NINDS with National Institutes of Health.
Nargiza Mansurova, PhD Mrs. Mansurova has nothing to disclose.
Yakutkhon Madjidova No disclosure on file
Ramazon Boymurodov No disclosure on file
Deborah A. Cory-Slechta No disclosure on file
Nicole Bonsavage, MD Dr. Bonsavage has nothing to disclose.
Louis Lotta No disclosure on file
Ergun Y. Uc, MD An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of Dr. Uc has received research support from Michael J. Fox Foundation. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH.
Alejandro Comellas, MD Dr. Comellas has nothing to disclose.
Joel Kline No disclosure on file
Jeffrey Dawson Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iotaMotion. The institution of Jeffrey Dawson has received research support from NIH, VA. Jeffrey Dawson has received personal compensation in the range of $0-$499 for serving as a Reviewer with Neurosurgery.
Nandakumar Narayanan, MD, PhD Dr. Narayanan has nothing to disclose.
Matthew Rizzo, MD, FAAN The institution of Dr. Rizzo has received research support from NIH. Dr. Rizzo has a non-compensated relationship as a Chair with ABC that is relevant to AAN interests or activities.
Michelle Voss, 7111 The institution of Michelle Voss, 7111 has received research support from NIH/NIA. The institution of Michelle Voss, 7111 has received research support from NIH/NIA. The institution of Michelle Voss, 7111 has received research support from NIH/NIMH. The institution of Michelle Voss, 7111 has received research support from NIH/NIA.
Steven W. Anderson, PhD Dr. Anderson has nothing to disclose.
Christina Weber, Other Mrs. Weber has nothing to disclose.
Warren Darling Warren Darling has stock in Bell Canada. The institution of Warren Darling has received research support from Department of Veteran Affairs. Warren Darling has received personal compensation in the range of $500-$4,999 for serving as a grant reviewer with NIH.
Katherine Conrad No disclosure on file
Michael Hast Michael Hast has received personal compensation for serving as an employee of Merz.
Jenna Abdelhadi Miss Abdelhadi has received personal compensation for serving as an employee of Aetion. Miss Abdelhadi has stock in Aetion.
Andrew Szendrey Mr. Szendrey has received personal compensation for serving as an employee of Aetion, Inc.
Amanda M. Kong, Other Dr. Kong has received personal compensation for serving as an employee of Aetion. Dr. Kong has stock in Aetion. The institution of Dr. Kong has received research support from Merz.
Rohan Shah The institution of Mr. Shah has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Merz. Mr. Shah has stock in Aetion. The institution of Mr. Shah has received research support from Merz.
Jordan Holmes, PhD Dr. Holmes has received personal compensation for serving as an employee of Merz Therapeutics.
Shivnaveen Bains, MD No disclosure on file
Katharine Ann Henry, MD Dr. Henry has nothing to disclose.
William Alexander Dalrymple, MD The institution of Dr. Dalrymple has received research support from Huntington's Disease Society of America.
Joseph Flanigan Joseph Flanigan has nothing to disclose.
Madaline B. Harrison, MD Dr. Harrison has nothing to disclose.
Renzo Figari-Jordan, MD Dr. Figari-Jordan has nothing to disclose.
Binit Shah, MD, FAAN Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Expert Institute.
Sara Trach, Other Dr. Trach has nothing to disclose.
M. Agustina Rossetti, PhD Dr. Rossetti has nothing to disclose.
James Patrie Mr. Patrie has nothing to disclose.
Derrece K. Reid, MD No disclosure on file
Ghazal Banisadr, PhD Dr. Banisadr has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Henry Paul Moore, MD Dr. Moore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie . Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC.
Richard D'Souza Richard DSouza has received personal compensation for serving as an employee of Amneal Pharmaceuticals. Richard DSouza has stock in Amneal Pharmaceuticals .
Xuemei Huang, MD, PhD No disclosure on file
Anindita Deb, MD, FAAN Dr. Deb has nothing to disclose.
Soaham Dilip Desai, MD, DM Dr. Desai has nothing to disclose.
Zahin Ahmed Mr. Ahmed has nothing to disclose.
W. Jeffrey Elias No disclosure on file
Riley Bove, MD, FAAN Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeurologyLive. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Roche Genentech. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Eli Lilly.
Ayushi Dinesh Balan Miss Balan has nothing to disclose.
Maria Pia Sormani Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Geneuro. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Maria K. Houtchens, MD Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cravath. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Beasley . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Biogen. The institution of Dr. Houtchens has received research support from Genzyme. The institution of Dr. Houtchens has received research support from Biogen. The institution of Dr. Houtchens has received research support from Genentech.
Zhenyuan Wang, PhD Dr. Wang has nothing to disclose.
Hugo Chaumont, MD Mr. Chaumont has nothing to disclose.
Thomas DAVID Mr. DAVID has nothing to disclose.
Annie Lannuzel, MD Dr. Lannuzel has nothing to disclose.
Benoit Tressières Benoit Tressières has nothing to disclose.
Philippe Cabre Philippe Cabre has nothing to disclose.
Christine DiVincenzo No disclosure on file
Malak AlMojel, MD Dr. AlMojel has nothing to disclose.
Samar Farouk Ahmed, MD Dr. Ahmed has nothing to disclose.
Jasem Yousef Al-Hashel, MD Dr. Al-Hashel has nothing to disclose.
Raed Alroughani, MD, FAAN Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Bayer, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer, Biogen, Novartis, Merck, Roche, Sanofi.
Christopher Elzinga No disclosure on file
Shivam Patel Mr. Patel has nothing to disclose.
Jaime Imitola, MD, FAAN Dr. Imitola has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . The institution of Dr. Imitola has received research support from biogen. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.
Seamus Rafferty Mr. Rafferty has nothing to disclose.
Laura Aquino, Other Miss Aquino has nothing to disclose.
Saloni Chadha Miss Chadha has nothing to disclose.
Richard Ginocchio, Other Mr. Ginocchio has nothing to disclose.
Brooke Cyr, Other Ms. Cyr has nothing to disclose.
Joshua C. Fedorko Mr. Fedorko has nothing to disclose.
Martin Bazinet No disclosure on file
Sophia Woodson Sophia Woodson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MSSA. Sophia Woodson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Sophia Woodson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Sophia Woodson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Sophia Woodson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb .
Edward John Gettings, DO Dr. Gettings has nothing to disclose.
Chu-Yueh Guo, MD Dr. Guo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Sylvia Klineova, MD Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Jong-Mi Lee, NP Ms. Lee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Ms. Lee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol meyers Squibb . Ms. Lee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Ms. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon.
Rebecca Romero, MD, FAAN Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Romero has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon.
Aljoeson Walker, MD No disclosure on file
Kinyee Fong, Other Dr. Fong has received personal compensation for serving as an employee of Biogen.
Jason P. Mendoza No disclosure on file
Nicholas Belviso, PhD, PharmD Dr. Belviso has received personal compensation for serving as an employee of Biogen.
Boyang Bian, PhD Mr. Bian has received personal compensation for serving as an employee of Biogen.
James B. Lewin, PharmD Dr. Lewin has received personal compensation for serving as an employee of Biogen. Dr. Lewin has stock in Biogen.
Sai L. Shankar, PhD, FAAN Dr. Shankar has received personal compensation for serving as an employee of Biogen. Dr. Shankar has stock in Biogen.
Sat Dev Batish, PhD, FAAN Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Manali Divyesh Shah, MD Dr. Shah has nothing to disclose.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche.
Brian Curran Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Naila Makhani, MD Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Institute for Advanced Clinical Trials for Children. The institution of Dr. Makhani has received research support from NIH/NINDS. The institution of Dr. Makhani has received research support from Charles H Hood Foundation. The institution of Dr. Makhani has received research support from National Multiple Sclerosis Society. Dr. Makhani has received personal compensation in the range of $0-$499 for serving as a contributor to online content with WebMD. Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a contributor to a CME video podcast and newsletter with eMultiple Sclerosis Review. Dr. Makhani has received personal compensation in the range of $5,000-$9,999 for serving as a consultant with I-ACT for children.
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique.
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Veronika Shabanova Veronika Shabanova has nothing to disclose.
Evangeline Wassmer, MD Dr. Wassmer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Wassmer has received research support from Birmingham Children's Hospital Charity Research Foundation.
Jonathan Santoro, MD Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma.
Sona Narula, MD Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape .
James Nick Brenton, MD Dr. Brenton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharmaceuticals. The institution of Dr. Brenton has received research support from NIH/NINDS. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Expert Interview with MDEdge. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH.
Soe Soe Mar, MD, FAAN The institution of Dr. Mar has received research support from NIH.
Francoise Durand Dubief The institution of Francoise Durand Dubief has received research support from ARSEP.
Helene Zephir Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Guillaume Mathey Guillaume Mathey has nothing to disclose.
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Silvia Tenembaum, MD Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech-Roche Inc. . Dr. Tenembaum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals Inc. .
Robert Ian Thompson-Stone, MD, FAAN Dr. Thompson-Stone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Conway Homer PC.
Olivier Casez, MD Dr. Casez has nothing to disclose.
Clarisse Carra-Dalliere Clarisse Carra-Dalliere has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Rinze F Neuteboom The institution of Rinze F Neuteboom has received research support from MS research foundation The Netherlands.
Nusrat Ahsan, MD Dr. Ahsan has nothing to disclose.
Hugo A. Arroyo, MD Dr. Arroyo has nothing to disclose.
Matilde Inglese, MD, PhD Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Celine Louapre Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Celine Louapre has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Celine Louapre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Celine Louapre has received research support from Biogen. The institution of Celine Louapre has received research support from Neuratris.
Monica Margoni Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Filipe Palavra Filipe Palavra has nothing to disclose.
Daniela Pohl Daniela Pohl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos.
Daniel Reich, MD,PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi-Genzyme. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with PeerView. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with AcademicCME. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Integrity. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi-Genzyme that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with American Brain Foundation that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Biohaven that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sana that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Merck KGaA EMD Serono that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Bristol-Meyers Squibb that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with ChemoCentryx that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Perceptive that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities.
Aurelie Ruet The institution of Aurelie Ruet has received research support from BIOGEN. The institution of Aurelie Ruet has received research support from ROCHE. The institution of Aurelie Ruet has received research support from SANOFI GENZYME. The institution of Aurelie Ruet has received research support from BMS. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Horizon therapeutic. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Alexion. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with BIOGEN. Aurelie Ruet has received personal compensation in the range of $500-$4,999 for serving as a Speaker meeting with MERCK. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with Sanofi Genzyme.
Eric Thouvenot, MD, PhD Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biologix FZCo.. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HEALTHME. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.
Niklas Timby, MD,PhD Dr. Timby has nothing to disclose.
Ugur Uygunoglu Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey.
Wendy Sulina Vargas, MD Dr. Vargas has received personal compensation for serving as an employee of Sanofi. The institution of Dr. Vargas has received research support from NICHD.
Helene Verhelst Helene Verhelst has nothing to disclose.
Ronny Wickström, MD,PhD The institution of Prof. Wickström has received research support from Stockholm City Council.
Christina Azevedo, MD, FAAN Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. The institution of Dr. Azevedo has received research support from National Institutes of Health/National Institutes of Neurological Disorders and Stroke. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society.
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
Eugene Shapiro, MD Dr. Shapiro has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. The institution of Dr. Shapiro has received research support from NIH. Dr. Shapiro has received publishing royalties from a publication relating to health care.
Darin T. Okuda, MD, FAAN Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RVL Pharmaceuticals, Inc.. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas BioPharma. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from EMD Serono. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Daniel Pelletier, MD Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Mar Tintore The institution of Mar Tintore has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Mar Tintore has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Mar Tintore has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Mar Tintore has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche . The institution of Mar Tintore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Mar Tintore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Mar Tintore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela bio. The institution of Mar Tintore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Mar Tintore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Mar Tintore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Mar Tintore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Mar Tintore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . The institution of Mar Tintore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Mar Tintore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel and UCB Biopharma. Mar Tintore has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal: Experimental, Translational and Clinical. The institution of Mar Tintore has received research support from Fundació La Marató de TV3. The institution of Mar Tintore has received research support from Instituto de Salud Carlos III. The institution of Mar Tintore has received research support from Instituto de Salud Carlos III.
Jessica Rochelle Fesler, MD Dr. Fesler has nothing to disclose.
Muhammad Faraz Raghib, MD Dr. Raghib has nothing to disclose.
Fen Bao Fen Bao has nothing to disclose.
ZL Liaquat, Other Mrs. Liaquat has nothing to disclose.
Eman Dannawey, Other Miss Dannawey has nothing to disclose.
Emily Pelc Ms. Pelc has nothing to disclose.
Carla E. Santiago-Martinez Ms. Santiago-Martinez has nothing to disclose.
Jacob Rube, MD Dr. Rube has nothing to disclose.
Evanthia Bernitsas, MD, FAAN Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen@Janssen. Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Mahmoud Elkhooly, MD Dr. Elkhooly has nothing to disclose.
Ryan Hakimi, DO, FAAN Dr. Hakimi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for South Carolina Osteopathic Medical Society. Dr. Hakimi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Hakimi has a non-compensated relationship as a Delegate, House of Delegates with American Medical Association that is relevant to AAN interests or activities. Dr. Hakimi has a non-compensated relationship as a Annual Meeting Course Committee Member or Organizer with Neurocritical Care Society that is relevant to AAN interests or activities.
Dalal Khaled Qasem, MD Dr. Qasem has nothing to disclose.
Shrenik Talsania No disclosure on file
Ilana B. Katz Sand, MD The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with American Academy of Neurology.
James F. Sumowski Mr. Sumowski has nothing to disclose.
Michelle Fabian, MD, FAAN Dr. Fabian has nothing to disclose.
Kathryn Fitzgerald, PhD The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Sammita Satyanarayan, MD Dr. Satyanarayan has nothing to disclose.
Emmaculate Mmboga Fields, NP Mrs. Fields has a non-compensated relationship as a Board of Directors and Treasurer with American Society of Neuroimaging that is relevant to AAN interests or activities.
Hannah Frances Todd, MPH Miss Todd has nothing to disclose.
Jonathan M. Yarimi, MD Dr. Yarimi has nothing to disclose.
Kristen Fisher, DO Dr. Fisher has nothing to disclose.
Timothy E. Lotze, MD, FAAN Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care.
Nikita Shukla, MD The institution of Dr. Shukla has received research support from Roche.
Alexander Sandweiss, MD, PhD Dr. Sandweiss has nothing to disclose.
Robert L. Carruthers, MD Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech .
Trieste Francis Miss Francis has nothing to disclose.
Heewon Hwang Mr. Hwang has nothing to disclose.
Dalia Rotstein, MD Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Rotstein has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Rotstein has received research support from CMSC. The institution of Dr. Rotstein has received research support from Roche Canada.
Federico Casales Mr. Casales has nothing to disclose.
Maria Claudia Burbano, MD Dr. Burbano has nothing to disclose.
Alejandra Heriz Alejandra Heriz has nothing to disclose.
Cecilia Adriana Gonzalez, Sr., MD,PhD Mrs. Gonzalez has nothing to disclose.
Jimena Miguez No disclosure on file
Ricardo Alonso Ricardo Alonso has nothing to disclose.
Berenice Silva SIlva Berenice has nothing to disclose.
Madeleine Rose Miss Rose has nothing to disclose.
Annika Anderson Annika Anderson has received personal compensation for serving as an employee of University of California, San Francisco.
Stephanie Hsu Ms. Hsu has nothing to disclose.
Cori *Use 296449 Polonski, MD Dr. Polonski has nothing to disclose.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Yang Yu, MD Dr. Yu has nothing to disclose.
Hani Kushlaf, MD, FAAN Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion AstraZeneca Rare Disease. Dr. Kushlaf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kushlaf has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Guy Jerome Buckle, MD No disclosure on file
Rachel Walsh, MD Dr. Walsh has nothing to disclose.
Keith Van Haren, MD Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
Orla Hardiman, MD, FRCP, FAAN Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Joyutpal Das, MBBS Dr. Das has nothing to disclose.
Gagana Kethaka Mallawa Arac Mallawaarachchi Mr. Mallawaarachchi has nothing to disclose.
David Rog, MBBS Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen-Cilag. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. The institution of Dr. Rog has received research support from Actelion. The institution of Dr. Rog has received research support from Biogen. The institution of Dr. Rog has received research support from MedDay. The institution of Dr. Rog has received research support from Merck. The institution of Dr. Rog has received research support from Mitsubishi. The institution of Dr. Rog has received research support from Novartis. The institution of an immediate family member of Dr. Rog has received research support from Sanofi Genzyme. The institution of Dr. Rog has received research support from TG Therapeutics. Dr. Rog has received research support from Janssen-Cilag.
Julio A. Chalela, MD Dr. Chalela has nothing to disclose.
Ron Neyens, Other Dr. Neyens has nothing to disclose.
Jimmy Suh, MD Dr. Suh has received publishing royalties from a publication relating to health care.
Niren Kapoor, MD, PhD Dr. Kapoor has nothing to disclose.
Charles Andrews, MD Dr. Andrews has nothing to disclose.
Vinita Dora No disclosure on file
Megan Barra Ms. Barra has received personal compensation for serving as an employee of Marinus Pharmaceuticals.
Sri Saikumar Mr. Saikumar has received personal compensation for serving as an employee of Trinity Life Sciences.
Saloni Shah Mrs. Shah has nothing to disclose.
Dushyant Katariya, Other Mr. Katariya has received personal compensation for serving as an employee of Trinity Life Sciences.
Adrienne Lovink Mrs. Lovink has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Trinity Life Sciences.
Henrikas Vaitkevicius, MD Dr. Vaitkevicius has received personal compensation for serving as an employee of Marinus Pharmaceuticals. Dr. Vaitkevicius has stock in Marinus Pharmaceuticals.
Eva Rybak, PharmD Dr. Rybak has received personal compensation for serving as an employee of Marinus Pharmaceuticals . Dr. Rybak has received stock or an ownership interest from Marinus Pharmaceuticals .
Miriam Quinlan, MD, MPH Dr. Quinlan has nothing to disclose.
Bakhtawar Ahmad, MBBS Dr. Ahmad has nothing to disclose.
Nicole Maranchick Dr. Maranchick has nothing to disclose.
Daniela Pomar Forero Dr. Pomar Forero has nothing to disclose.
Katharina M. Busl, MD, MS, FAAN Dr. Busl has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. The institution of Dr. Busl has received research support from University of Florida Self Insurance Program. The institution of Dr. Busl has received research support from National Institutes of Health. Dr. Busl has a non-compensated relationship as a Board Member with Art in Medicine that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Associate Editor with Critical Care Explorations that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Editorial Board Member with Neurocritical Care that is relevant to AAN interests or activities.
Maria J. Bruzzone, MD Dr. Bruzzone has nothing to disclose.
Charles Peloquin, Other The institution of Prof. Peloquin has received research support from Paratek. The institution of Prof. Peloquin has received research support from AbbVie. The institution of Prof. Peloquin has received research support from NIAID.
Carolina B. Maciel, MD, MSCR, FAAN Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health.
Stephan Eisenschenk, MD Dr. Eisenschenk has nothing to disclose.
Alex Chen No disclosure on file
Sérgio Brasil, MD,PhD Dr. Brasil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brain4care.
Danilo Cardim, PhD Dr. Cardim has received personal compensation for serving as an employee of Brain4care.
Fabio Taccone No disclosure on file
Jade Marshall, Other Ms. Marshall has nothing to disclose.
Emerson Barrett Nairon Ms. Nairon has nothing to disclose.
DaiWai Olson DaiWai Olson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Minnetronix. The institution of DaiWai Olson has received research support from Neuroptics. The institution of DaiWai Olson has received research support from Ceribell.
Alec Gomba Mr. Gomba has nothing to disclose.
Dawit G. Measho Mr. Measho has nothing to disclose.
Lindsay McEver, RN Miss McEver has nothing to disclose.
Brittany Renee Doyle, RN Mrs. Doyle has nothing to disclose.
Richard Moberg, Other Mr. Moberg has received personal compensation for serving as an employee of Moberg Analytics, Inc.. Mr. Moberg has stock in Moberg Analytics, Inc.. The institution of Mr. Moberg has received research support from U.S. Dept of Defense.
Susan Ettner No disclosure on file
Patricia Bacus, MD Dr. Bacus has nothing to disclose.
Khadija Jadun, MD,MBBS Dr. Jadun has nothing to disclose.
Zahra Haghighat, MD Dr. Haghighat has nothing to disclose.
Ima M. Ebong, MD The institution of Dr. Ebong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB.
Devin Dean Mackay, MD Dr. Mackay has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms.
Valerie Biousse, MD Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurophoenix. The institution of Dr. Biousse has received research support from NIH. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Mariana Rodriguez Duran Mrs. Rodriguez Duran has nothing to disclose.
Mariam Torres Soto Ms. Torres Soto has nothing to disclose.
Andrew Pendley No disclosure on file
David Wright David Wright has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Chambless, Higdon, Richardson, Katz, Griggs, LLP. David Wright has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Grower, Ketcham, Eide, Telan, Meltz PA. The institution of David Wright has received research support from NIH.
Nancy J. Newman, MD, FAAN Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophoenix. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Chiesi/Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Gabriele Berman, MD Dr. Berman has nothing to disclose.
James G. Greene, MD, PhD Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology.
Philip Garza No disclosure on file
Sara LaHue, MD The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Larry L. Hillblom Foundation . The institution of Dr. LaHue has received research support from UCSF Claude D. Pepper Older Americans Independence Center . The institution of Dr. LaHue has received research support from UCSF Bakar Aging Research Institute. The institution of Dr. LaHue has received research support from Doris Duke Foundation . Dr. LaHue has received publishing royalties from a publication relating to health care.
Vanja C. Douglas, MD Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
Ori Lieberman, MD, PhD Dr. Lieberman has received research support from UCSF.
Beau Benjamin Bruce, MD, FAAN Dr. Bruce has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bayer.
Samuel Bidot Samuel Bidot has nothing to disclose.
Maria E. Baldwin, MD Dr. Baldwin has nothing to disclose.
Jonathan Elmer The institution of Jonathan Elmer has received research support from NIH.
Florian B. Mayr, MD Dr. Mayr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Baxter Healthcare Inc.
Kristen Rahall, NP Mrs. Rahall has nothing to disclose.
Veronique Belzil No disclosure on file
Fiona Grimson, PhD Dr. Grimson has received personal compensation for serving as an employee of UCB Pharma. Dr. Grimson has stock in UCB Pharma.
Asha Hareendran Asha Hareendran has received personal compensation for serving as an employee of UCB. Asha Hareendran has stock in UCB. Asha Hareendran has stock in Pfizer.
Klaus Elenius No disclosure on file
Monique Bastidas Dr. Bastidas has stock in Pfizer, Moderna, BioNTech SE, Catalyst Pharmaceuticals. An immediate family member of Dr. Bastidas has stock in Pfizer.
Michael Zikry Mr. Zikry has stock in Novavax Inc.
Brandon M. Bauer, PhD Mr. Bauer has nothing to disclose.
Kelly Y. Chun, PhD Dr. Chun has nothing to disclose.
Guy A. Rouleau, MD, PhD, FAAN Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
Zaeem A. Siddiqi, MD, PhD Dr. Siddiqi has nothing to disclose.
Angela L. Genge, MD Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE.
Cynthia Zhengyun Qi, Other Ms. Qi has received personal compensation for serving as an employee of argenx.
Allen Zhou Mr. Zhou has received personal compensation for serving as an employee of EVERSANA.
Roger Kaprielian Roger Kaprielian has nothing to disclose.
Jason J. Locklin, Other Mr. Locklin has received personal compensation for serving as an employee of Argenx Canada. Mr. Locklin has stock in argenx.
David A. Garcia, MD Dr. Garcia has received personal compensation for serving as an employee of EVERSANA.
Asao Fujiyama No disclosure on file
Bhaskar Roy, MD Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has stock in Cabaletta bio. . The institution of Dr. Roy has received research support from Martin Shubik Fund for IBM at Yale University. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals.
Richard J. Nowak, MD Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. The institution of Dr. Nowak has received research support from Ra Pharma. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Momenta . The institution of Dr. Nowak has received research support from Immunovant . Dr. Nowak has received research support from argenx. Dr. Nowak has received research support from Viela Bio . Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Shinichi Morishita No disclosure on file
Carolina Barnett Tapia, MD Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $0-$499 for serving as a Consultant for Sanofi. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Sophie Lehnerer, MD Dr. Lehnerer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Lehnerer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. The institution of Dr. Lehnerer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lehnerer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. Lehnerer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Lehnerer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Lehnerer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Lehnerer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hormosan.
Laïtissia AHAMADA, Jr. Mrs. AHAMADA has received personal compensation for serving as an employee of Ad Scientiam.
Loic Carment, PhD Dr. Carment has received personal compensation for serving as an employee of Ad Scientiam.
Kenza Drareni, PhD Dr. Drareni has received personal compensation for serving as an employee of Ad scientiam.
Pierre DROUIN, PhD Dr. DROUIN has received personal compensation for serving as an employee of Ad Scientiam.
Clarissa Gorin, Other Dr. Gorin has received personal compensation for serving as an employee of Ad Scientiam.
Dellini Ravindra Miss Ravindra has received personal compensation for serving as an employee of Ad Scientiam.
Emma Touré Cuq, Other Mrs. Touré Cuq has received personal compensation for serving as an employee of Ad Scientiam .
Alizé Vives, Other Dr. Vives has received personal compensation for serving as an employee of Ad Scientiam.
Emrah Aras, MD Dr. Aras has received personal compensation for serving as an employee of Alexion Pharmaceuticals Inc.
Martin Keller, PhD Dr. Keller has received personal compensation for serving as an employee of Alexion. Dr. Keller has stock in Alexion, Roche, Novartis, Celgene, Abbvie, Merck, Ionis, Sanofie, Organon, MSD.
Saad Zinai Saad Zinai has received personal compensation for serving as an employee of Ad Scientiam.
Jun Goto, MD, PhD No disclosure on file
Louis Jackson, PharmD Dr. Jackson has received personal compensation for serving as an employee of Janssen Pharmaceuticals.
Jacqueline Pesa, PhD Dr. Pesa has received personal compensation for serving as an employee of Janssen. Dr. Pesa has stock in J&J.
Caroline Brethenoux Mrs. Brethenoux has received personal compensation for serving as an employee of Cien+ .
Alyssa DeLuca Miss DeLuca has nothing to disclose.
Patrick Furey, Jr. Mr. Furey has nothing to disclose.
Rosario Alvarez Miss Alvarez has nothing to disclose.
Laura Gonzalez Quijano Miss Gonzalez Quijano has nothing to disclose.
Alex Lorenzo Mr. Lorenzo has nothing to disclose.
Ashley E. Anderson, MD Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/Johnson&Johnson. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Zia Ulhaq Chaudhry, MD,PhD Dr. Chaudhry has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Chaudhry has received personal compensation for serving as an employee of Takeda Pharmaceuticals.
Shoji Tsuji, MD, PhD The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Neelam Goyal, MD Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Srikanth Muppidi, MD, FAAN Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Suraj Muley, MD, FAAN Dr. Muley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Muley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Muley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Muley has received publishing royalties from a publication relating to health care.
Nakul Katyal, MD Dr. Katyal has nothing to disclose.
Sean C. Rose, MD, FAAN The institution of Dr. Rose has received research support from Dale Earnhardt Jr Foundation.
Vern C. Juel, MD, FAAN Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accordant Health Services. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Andrew J. Gordon, MD Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion . Dr. Gordon has received personal compensation in the range of $0-$499 for serving as a Consultant for Vertex. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Gordon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Gordon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Gordon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cassiday.
Ericka P. Greene, MD, FAAN Dr. Greene has received personal compensation for serving as an employee of Argenx. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion, Inc. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylx. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis . Dr. Greene has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ABPN.
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/ Ra Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze Therapeutics. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institutes of Health. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neuromuscular Disease Foundation. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi-Genzyme. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Spark Therapeutics. The institution of Dr. Mozaffar has received research support from Audentes Therapeutics. The institution of Dr. Mozaffar has received research support from Cartesian. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
James M. Winkley, MD Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biogen. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Sanofi. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Novartis. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Serrono. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Teva. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Biogen. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Sanofi. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Serrono. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Novartis. Dr. Winkley has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Roche. Dr. Winkley has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Winkley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Winkley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for lilly. Dr. Winkley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. The institution of Dr. Winkley has received research support from Noveratis. The institution of Dr. Winkley has received research support from Merck. The institution of Dr. Winkley has received research support from Sanofi. The institution of Dr. Winkley has received research support from Biogen. The institution of Dr. Winkley has received research support from Alexion.
Ema Rodrigues, Other Dr. Rodrigues has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Rodrigues has stock in Alexion Pharmaceuticals.
Guido Sabatella Guido Sabatella has received personal compensation for serving as an employee of Alexion.
Rup Tandan, MD, FRCP, FAAN Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Apellis. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Tandan has received research support from Alexion. The institution of Dr. Tandan has received research support from Apellis. The institution of Dr. Tandan has received research support from Cytokinetics.
Anastasia H. Fischer, MD No disclosure on file
Chiara Pane, MD Dr. Pane has nothing to disclose.
Alessio Sarnataro, MD Dr. Sarnataro has nothing to disclose.
Nunzia Cuomo, MD Dr. Cuomo has nothing to disclose.
Angela *use 392437 Marsili No disclosure on file
Giorgia Puorro No disclosure on file
Mario Campanile, PhD Dr. Campanile has nothing to disclose.
Francesco Sacca, MD Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Geoffrey Lyle Heyer, MD No disclosure on file
Rasha Moussallem, MD Dr. Moussallem has nothing to disclose.
Husam Al Sultani Husam Al Sultani has nothing to disclose.
Christelle Haddad, MD Dr. Haddad has nothing to disclose.
Rocio Carolina Garcia Santibanez, MD, FAAN Dr. Garcia Santibanez has nothing to disclose.
Shaida Khan, DO Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Chamblee Ryan .
Thy Nguyen, MD Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ArgenX. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Nguyen has received publishing royalties from a publication relating to health care.
Yessar M. Hussain, MD The institution of Dr. Hussain has received research support from Alnylam Pharma.
Aziz I. Shaibani, MD, FAAN Dr. Shaibani has nothing to disclose.
Cristina M. Ramo, MD Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANDOZ. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ramo has received research support from HORIZON-2020. The institution of Dr. Ramo has received research support from fis (SPANISH GOVERNMENT). The institution of Dr. Ramo has received research support from BIOGEN. The institution of Dr. Ramo has received research support from MERCK. The institution of Dr. Ramo has received research support from ALMIRALL. The institution of Dr. Ramo has received research support from NOVARTIS. The institution of Dr. Ramo has received research support from RICORS (Spanish Government). The institution of Dr. Ramo has received research support from ROCHE. Dr. Ramo has received publishing royalties from a publication relating to health care.
Porpong Boonmak, MD,PhD Dr. Boonmak has received personal compensation for serving as an employee of Analysis Group, Inc.
Maryia Zhdanava Ms. Zhdanava has received personal compensation for serving as an employee of Analysis Group.
Samuel A. Schwartzbein Mr. Schwartzbein has received personal compensation for serving as an employee of Analysis Group.
Qian Cai, Other Ms. Cai has received stock or an ownership interest from J&J.
Dominic Pilon Mr. Pilon has received personal compensation for serving as an employee of Analysis Group, Inc..
Marie-Helene Lafeuille Marie-Helene Lafeuille has nothing to disclose.
Patrick Lefebvre The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Acadia Pharmaceuticals. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for GSK. The institution of Patrick Lefebvre has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Janssen Scientific Affairs. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Novartis. The institution of Patrick Lefebvre has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Otsuka. The institution of Patrick Lefebvre has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Pharmacyclics. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pfizer. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Regeneron.
Laia Grau-Lopez No disclosure on file
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Arman Cakar Arman Cakar has nothing to disclose.
Fatma Yesim Parman, MD Dr. Parman has nothing to disclose.
Lucas Adams No disclosure on file
Sandeep Kiri Mr. Kiri has received personal compensation for serving as an employee of UCB. Mr. Kiri has stock in UCB.
Kerrie-Anne Ho, PhD Dr. Ho has received personal compensation for serving as an employee of UCB. Dr. Ho has stock in UCB.
Carol Mansfield Carol Mansfield has received personal compensation for serving as an employee of RTI Health Solutions.
Anna Pierce, Other Miss Pierce has received personal compensation for serving as an employee of RTI International.
Caroline Mary Vass, PhD Dr. Vass has received personal compensation for serving as an employee of RTI Health Solutions.
Xiaoying Liu, PhD Dr. Liu has received personal compensation for serving as an employee of RTI Health Solutions.
Alex Rovira Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofy. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Alex Rovira has stock in Tensor Medical.
Alexis King Mrs. King has nothing to disclose.
Michael Blackowicz, PhD Dr. Blackowicz has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Blackowicz has stock in Alexion Pharmaceuticals.
Shirali Pandya, PhD Dr. Pandya has received personal compensation for serving as an employee of Alexion, Astra Zeneca Rare Disease. Dr. Pandya has received personal compensation for serving as an employee of Rhythm Pharmaceuticals. Dr. Pandya has stock in Sanofi. Dr. Pandya has stock in Alexion, Astra Zeneca Rare Disease.
Daniel Basoff, PharmD, RPh Dr. Basoff has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Aaron Carabajal-Johnson, Other The institution of Dr. Carabajal-Johnson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Inovalon Insights.
Philip Chan, PhD The institution of Dr. Chan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Inovalon. Dr. Chan has stock in AstraZeneca.
Nana Oduro Numapau Dr. Numapau has received personal compensation for serving as an employee of Alexion Pharmaceutical. Dr. Numapau has stock in Alexion Pharmaceutical.
Andrew Whipkey No disclosure on file
Joel Arackal Dr. Arackal has nothing to disclose.
Jingyu Wang Miss Wang has received personal compensation for serving as an employee of Roivant Sciences.
Jennifer Schwinn Jennifer Schwinn has received personal compensation for serving as an employee of Immunovant, Inc..
Brett Venker, Other Dr. Venker has received personal compensation for serving as an employee of Roivant Sciences. Dr. Venker has stock in Roivant Sciences.
Paola Mina-Osorio, MD, PhD Dr. Mina-Osorio has received personal compensation for serving as an employee of Immunovant. Dr. Mina-Osorio has stock in Immunovant, Inc..
Anza Memon, MD, FAAN Dr. Memon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutic .
Jiachen Zhou, PhD Dr. Zhou has received personal compensation for serving as an employee of UCB Pharma. Dr. Zhou has stock in UCB Pharma.
SIGRID Maria NILIUS, PhD Dr. NILIUS has received personal compensation for serving as an employee of UCB Pharma.
Olga Pilipczuk Ms. Pilipczuk has received personal compensation for serving as an employee of UCB.
Anna Scowcroft Mrs. Scowcroft has received personal compensation for serving as an employee of UCB. Mrs. Scowcroft has stock in UCB. Mrs. Scowcroft has stock in Pfizer.
Frank Tennigkeit, PhD Dr. Tennigkeit has received personal compensation for serving as an employee of UCB Biosciences. Dr. Tennigkeit has stock in UCB Biosciences.
Piotr Zaremba Mr. Zaremba has nothing to disclose.
John Brandsema, MD Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fibrogen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise. The institution of Dr. Brandsema has received research support from Novartis. The institution of Dr. Brandsema has received research support from Biogen. The institution of Dr. Brandsema has received research support from Alexion. The institution of Dr. Brandsema has received research support from CSL Behring. The institution of Dr. Brandsema has received research support from Pfizer. The institution of Dr. Brandsema has received research support from PTC Therapeutics. The institution of Dr. Brandsema has received research support from Sarepta. The institution of an immediate family member of Dr. Brandsema has received research support from Argenx. The institution of Dr. Brandsema has received research support from Astellas. The institution of Dr. Brandsema has received research support from Fibrogen. The institution of Dr. Brandsema has received research support from Genentech. The institution of Dr. Brandsema has received research support from Janssen. The institution of Dr. Brandsema has received research support from Scholar Rock.
Thais Tarancon Heras, Sr., MD Dr. Heras has received personal compensation for serving as an employee of UCB Pharma S.A.
Kumar Rajamani, MD, FAAN Dr. Rajamani has nothing to disclose.
Steven Vernino, MD, PhD, FAAN Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Grifols. The institution of Dr. Vernino has received research support from Dysautonomia International. The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. Dr. Vernino has received personal compensation in the range of $10,000-$49,999 for serving as a Content Expert Consultant with Office of Inspector General for Medicare. Dr. Vernino has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities.
David Morrell, Other Mr. Morrell has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Mr. Morrell has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Catalyst Pharmaceuticals. Mr. Morrell has stock in Catalyst Pharmaceuticals.
Guy Shechter, PhD Dr. Shechter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Catalyst Pharmaceuticals, Inc..
Jeffrey Rosenfeld, PhD, MD, FAAN Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ML Biosolutions. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amylyx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anelixis. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Strongbridge Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Rosenfeld has received research support from MT Pharma. The institution of Dr. Rosenfeld has received research support from Alexion. The institution of Dr. Rosenfeld has received research support from Healey ALS Trial Center Mass General.
Regina Grebla, PhD Dr. Grebla has received personal compensation for serving as an employee of Northeast Epi.
Robert P. Lisak, MD, FAAN Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Rachelle D. Rodriguez, PhD Dr. Rodriguez has received personal compensation for serving as an employee of Janssen Pharmaceuticals. Dr. Rodriguez has received personal compensation for serving as an employee of Purdue Pharma. Dr. Rodriguez has stock in Johnson and Johnson.
Wesley Peters, Other Mr. Peters has received personal compensation for serving as an employee of CorEvitas.
Gabrielle Geonnotti Ms. Geonnotti has nothing to disclose.
Maria Ait Tihyaty, PhD Dr. Ait Tihyaty has received personal compensation for serving as an employee of Janssen.
Robert Alexander Joshua, MD Dr. Joshua has nothing to disclose.
Christina Marini Ms. Marini has nothing to disclose.
Julia Helene Greenberg, MD Dr. Greenberg has a non-compensated relationship as a Editorial Board Member with Neurology Resident and Fellow Section that is relevant to AAN interests or activities.
Sophia Tsz Sum Tong Ms. Tong has nothing to disclose.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society.
Sujata P. Thawani, MD Dr. Thawani has nothing to disclose.
Azizi Seixas Azizi Seixas has nothing to disclose.
Kiril Kiprovski, MD Dr. Kiprovski has nothing to disclose.
Ricardo Osorio, MD Dr. Osorio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia.
Ferran Torres No disclosure on file
Elizabeth R. Gerstner, MD Dr. Gerstner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Midatech. Dr. Gerstner has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Gerstner Family Foundation. The institution of Dr. Gerstner has received research support from NCI.
Julie JoAnn Miller, MD Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Miller has received research support from NINDS. The institution of Dr. Miller has received research support from American Cancer Society - IRG Pilot Grant. The institution of Dr. Miller has received research support from Karyopharm. The institution of Dr. Miller has received research support from NCI.
Maya Viera, Other Miss Viera has nothing to disclose.
Hetal Mistry, MD An immediate family member of Dr. Mistry has received personal compensation for serving as an employee of Regeneron.
Sasmit Sarangi, MBBS, MD The institution of Dr. Sarangi has received research support from Fore biotherapeutics.
Eric Tai-Lee Wong, MD, FAAN Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cancer Commons. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Jose Vicente *use 253376 Hervas No disclosure on file
Artur Menegaz de Almeida Mr. Menegaz de Almeida has nothing to disclose.
Gabriel Marinheiro Marinheiro Dos Santos-Bezerra, Sr., Other Mr. Dos Santos-Bezerra has nothing to disclose.
Jessica Hoffmann Relvas, MD Miss Hoffmann Relvas has nothing to disclose.
Lucca Moreira Moreira Lopes, MD Mr. Moreira Lopes has nothing to disclose.
Gustavo Lima Guilherme, Sr. Mr. Guilherme has nothing to disclose.
João Antônio Zanette Giusti Mr. Zanette Giusti has nothing to disclose.
Paloma Soares Oliveira, Other Miss Oliveira has nothing to disclose.
Mauro André Azevedo Silva Cabral Mr. Cabral has nothing to disclose.
Renato Carvalho Santos, Sr., MD Dr. Carvalho Santos has nothing to disclose.
Khalid Medani, MD Dr. Medani has nothing to disclose.
Patricia Cechinel Mende Viana Ms. Viana has nothing to disclose.
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen. The institution of Dr. Montalban has received research support from BMS/ Celgene.
John Paul Aboubechara, MD, PhD Dr. Aboubechara has nothing to disclose.
Orwa Aboud, MD, PhD Dr. Aboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier.
Orin Bloch Orin Bloch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BrainLab. The institution of Orin Bloch has received research support from NIH.
Han Lee An immediate family member of Han Lee has received personal compensation for serving as an employee of Theravance inc. An immediate family member of Han Lee has received stock or an ownership interest from theravance.
Oliver Fiehn, PhD Dr. Fiehn has received personal compensation in the range of $0-$499 for serving as a reviewer with NIH.
Ruben Fragoso Ruben Fragoso has nothing to disclose.
Jonathan W. Riess, MD Dr. Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Daiichi-Sankyo. Dr. Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Riess has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merus. Dr. Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Riess has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Riess has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Riess has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Riess has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SeaGen. Dr. Riess has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Riess has received research support from Merck. The institution of Dr. Riess has received research support from Novartis. The institution of Dr. Riess has received research support from Spectrum. The institution of Dr. Riess has received research support from Revolution Medicine. The institution of Dr. Riess has received research support from IO Biotech. The institution of Dr. Riess has received research support from Arrivent. The institution of Dr. Riess has received research support from Kinnate. The institution of Dr. Riess has received research support from AstraZeneca.
Rawad Hodeify, PhD Dr. Hodeify has nothing to disclose.
Yin Allison Liu, MD Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Liu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Joan Costa No disclosure on file
Ryan Rilinger Mr. Rilinger has nothing to disclose.
Christine Cordova No disclosure on file
Andrew Dhawan, MD Dr. Dhawan has nothing to disclose.
Lubov Zeifman No disclosure on file
Catherine R. Garcia, MD Dr. Garcia has nothing to disclose.
Stephanie Renee' Knight, NP Ms. Knight has nothing to disclose.
Vinaykumar Puduvalli, MD Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec . Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newave . Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec, Novocure, Bayer, Servier, . An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newave . Dr. Puduvalli has stock in Gilead. Dr. Puduvalli has stock in Moderna. The institution of Dr. Puduvalli has received research support from Merck, Servier, Bexion, Karyopharm, Samus therapeutics.
Carlos Kamiya-Matsuoka, MD Dr. Kamiya-Matsuoka has nothing to disclose.
William Eddy No disclosure on file
Ruben Jauregui, MD Dr. Jauregui has nothing to disclose.
Mekka Rae Garcia, MD Dr. Garcia has nothing to disclose.
Devorah Segal, MD Dr. Segal has nothing to disclose.
Aarushi Jain Miss Jain has nothing to disclose.
Oscar L. Lopez, MD, FAAN Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck.
Syed Faaiz Enam, MBBS, PhD Dr. Enam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Emory University. Dr. Enam has stock in Thermeutics, LLC. Dr. Enam has received intellectual property interests from a discovery or technology relating to health care.
Mahabad Barwari Ms. Barwari has nothing to disclose.
Aksharkumar Dobariya Mr. Dobariya has nothing to disclose.
Reed Chen Mr. Chen has received intellectual property interests from a discovery or technology relating to health care.
Ravi V. Bellamkonda, PhD Prof. Bellamkonda has nothing to disclose.
Toral R. Patel, MD Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Elekta. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Elekta. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GT Medical Technologies. An immediate family member of Dr. Patel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mann Morrow, PLLC. The institution of Dr. Patel has received research support from NINDS. The institution of Dr. Patel has received research support from NIH/NCI. The institution of Dr. Patel has received research support from CPRIT. The institution of Dr. Patel has received research support from NIH/NCI. The institution of Dr. Patel has received research support from Ben and Catherine Ivy Foundation. Dr. Patel has received intellectual property interests from a discovery or technology relating to health care.
Ankur *use 273846 Patel, MD Dr. Patel has nothing to disclose.
Lewis H. Kuller No disclosure on file
Maria A. Minor, MD Dr. Minor has nothing to disclose.
Justin Thomas Low, MD, PhD Dr. Low has nothing to disclose.
Gregory Chamberlin, MD Dr. Chamberlin has nothing to disclose.
Vanessa Louise Smith Dr. Smith has nothing to disclose.
Karra A. Jones Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astellas Gene Therapies (formerly Audentes Therapeutics, Inc.). The institution of Dr. Jones has received research support from NIH.
Kevin Stevenson Mr. Stevenson has nothing to disclose.
William Jeck, MD,PhD An immediate family member of Dr. Jeck has received personal compensation for serving as an employee of Seagen Inc. The institution of Dr. Jeck has received research support from Priya Therapeutics.
Cyrus A. Raji, MD, PhD Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainreader ApS. Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Health . Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neurevolution Medicine.
Devi Veerappan Miss Veerappan has nothing to disclose.
Reena Parada Thomas, MD, PhD The institution of Dr. Thomas has received research support from NIH. The institution of Dr. Thomas has received research support from Health Resources & Services Administration. The institution of Dr. Thomas has received research support from California Institute of Regenerative Medicine. Dr. Thomas has received intellectual property interests from a discovery or technology relating to health care.
James T. Becker, PhD No disclosure on file
Emad Singer, MD Dr. Singer has received personal compensation for serving as an employee of MD Anderson Cancer Center.
Hebatalla M. Farouk No disclosure on file
Amr Moursi, MD Mr. Moursi has nothing to disclose.
Abdelrahman Reda Ali Youssef Dr. Youssef has nothing to disclose.
Mohamed Mahmoud Fathy Elmallahy, MD Dr. Elmallahy has nothing to disclose.
Hazem Shehta Ghaith No disclosure on file
Shrouk Fawze Mohamed Dr. Mohamed has nothing to disclose.
Mayowa Owolabi, MD, FAAN Dr. Owolabi has nothing to disclose.
Samantha Banks, MD Dr. Banks has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
Anastasia Zekeridou, MD, PhD The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Paul Decker, Other Mr. Decker has nothing to disclose.
Ronald Go Ronald Go has nothing to disclose.
Jithma Abeykoon, MD Dr. Abeykoon has nothing to disclose.
Gaurav Goyal, MD The institution of Dr. Goyal has received personal compensation in the range of $0-$499 for serving as a Consultant for 2nd.MD. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Opna Bio.
Jason Robert Young, MD Dr. Young has nothing to disclose.
Matthew Koster Matthew Koster has nothing to disclose.
Robert Vassallo The institution of Robert Vassallo has received research support from Pfizer . The institution of Robert Vassallo has received research support from SunPharma.
Jay Ryu, MD Dr. Ryu has nothing to disclose.
Caroline Davidge-Pitts, MD Dr. Davidge-Pitts has nothing to disclose.
Aishwarya Ravindran, MD Dr. Ravindran has nothing to disclose.
Julio Sartori-Valinotti, MD Dr. Sartori-Valinotti has nothing to disclose.
N. Nora Bennani, MD Dr. Bennani has nothing to disclose.
Mithun Shah, MD,PhD The institution of Dr. Shah has received research support from Archer Dx.
Karen Rech, MD Dr. Rech has nothing to disclose.
Corrie Bach, MD Dr. Bach has nothing to disclose.
Jeanette Eckel-Passow, PhD The institution of Dr. Eckel-Passow has received research support from NIH. Dr. Eckel-Passow has received intellectual property interests from a discovery or technology relating to health care.
W. Oliver Tobin, MBBCh, BAO, PhD,FAAN The institution of Dr. Tobin has received research support from Mallinckrodt. Dr. Tobin has received publishing royalties from a publication relating to health care. Dr. Tobin has received personal compensation in the range of $500-$4,999 for serving as a Speaker with NeurologyLive.
Atinuke Agunloye No disclosure on file
Nara Michaelson, MD The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS).
Joshua A. Budhu, MD Dr. Budhu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Budhu has received research support from BMSF. The institution of Dr. Budhu has received research support from Gilead Sciences. Dr. Budhu has received personal compensation in the range of $500-$4,999 for serving as a Peer Reviewer with Medscape.
Anu Bakare-Okpala, MD Dr. Bakare-Okpala has nothing to disclose.
Amanda Watsula Miss Watsula has nothing to disclose.
Maliheh Mohamadpour, MD Dr. Mohamadpour has nothing to disclose.
Ugonma Nnenna Chukwueke, MD Dr. Chukwueke has nothing to disclose.
Hugo Botha, MD Dr. Botha has received research support from NIH.
Yangyiran Xie Miss Xie has nothing to disclose.
Sukhman Singh Parhar, Other An immediate family member of Mr. Parhar has stock in Apple.
Shreya Sri Gunda Ms. Gunda has nothing to disclose.
Xinran Qi Ms. Qi has nothing to disclose.
Kekoa Taparra, MD,PhD The institution of Dr. Taparra has received research support from ASCO. Dr. Taparra has received research support from Stanford Cancer Institute. Dr. Taparra has received publishing royalties from a publication relating to health care.
Armaan Jamal Mr. Jamal has nothing to disclose.
George Hung Mr. Hung has nothing to disclose.
Nicholas Kikuta, Other Mr. Kikuta has nothing to disclose.
Adrian Matias Bacong, PhD The institution of Dr. Bacong has received research support from American Heart Association.
Gloria S. Kim Dr. Kim has nothing to disclose.
Latha Palaniappan, MD Dr. Palaniappan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Edge. Dr. Palaniappan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen.
Malathi Srinivasan, MD Dr. Srinivasan has nothing to disclose.
Joseph Duffy The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care.
Ibraheem Mashhour Alkhawaldeh, MD Dr. Alkhawaldeh has nothing to disclose.
Mostafa Hossam El Din Moawad, Other Dr. El Din Moawad has nothing to disclose.
Mohammad Al-Jafari, MD Dr. Al-Jafari has nothing to disclose.
Layan Hassan Darwish, MD Miss Darwish has nothing to disclose.
Amro Al-Qurm Mr. Al-Qurm has nothing to disclose.
Hamza Khaled Mohamma Alsalhi, MD Dr. Alsalhi has nothing to disclose.
Yasmeen Jamal Al-abdallat, MD Miss Al-abdallat has nothing to disclose.
Sadeen Zein Eddin, MD Miss Zein Eddin has nothing to disclose.
Mahmoud Shaban Abdelgalil, MBBS Dr. Shaban Abdelgalil has nothing to disclose.
Safa Odeh, MD Miss Odeh has nothing to disclose.
Edythe Strand No disclosure on file
Amira Mohamed Taha, MD Dr. Mohamed Taha has nothing to disclose.
Jenan Walid Aamar, PhD Dr. Aamar has received personal compensation for serving as an employee of jordan hospital. An immediate family member of Dr. Aamar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for rania al-abdallah prince hospital. An immediate family member of Dr. Aamar has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for rania al-abdallah prince hospital.
Omar Alsayed Kaoud, II, MD Dr. Kaoud has nothing to disclose.
Ibrahim *USE ID 385479 Serag Dr. Serag has nothing to disclose.
Taha Fayad No disclosure on file
Mohammed Ahmed Sadeq, MBBS Dr. Sadeq has nothing to disclose.
Khaled Albakri Mr. Albakri has nothing to disclose.
Abdulqadir J. Nashwan, PhD Mr. Nashwan has nothing to disclose.
Julia Michelle Landry Ms. Landry has nothing to disclose.
Gabriella Marie Bognet, Other Ms. Bognet has nothing to disclose.
Sarah Grace Ahr, Other Ms. Ahr has nothing to disclose.
Shakti Ramkissoon, MD Dr. Ramkissoon has received personal compensation for serving as an employee of Labcorp. Dr. Ramkissoon has stock in Labcorp.
Michael Chan Michael Chan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biomimetix. Michael Chan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Monteris.
Christina Cramer Christina Cramer has nothing to disclose.
Stephen B. Tatter, MD The institution of Dr. Tatter has received research support from Monteris Medical, Inc. The institution of Dr. Tatter has received research support from Arbor Pharmaceuticals. Dr. Tatter has received intellectual property interests from a discovery or technology relating to health care.
Adrian Laxton Adrian Laxton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Adrian Laxton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Monteris .
Jaclyn White, MD Dr. White has nothing to disclose.
Eric Severson, MD,PhD Dr. Severson has received personal compensation for serving as an employee of Labcorp.
Zachary D. Wallen, PhD Dr. Wallen has received personal compensation for serving as an employee of Labcorp.
Fang-Chi Hsu Fang-Chi Hsu has nothing to disclose.
Glenn Lesser Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cancer Expert Now. Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SDP Oncology. Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incysus . Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharma. Glenn Lesser has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Glenn Lesser has received research support from Denovo Biopharma. The institution of Glenn Lesser has received research support from Oblato . The institution of Glenn Lesser has received research support from Novocure. The institution of Glenn Lesser has received research support from GBM Agile - GCAR.
Roy E. Strowd, III, MD, FAAN Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Ryan Mott Ryan Mott has nothing to disclose.
Kimberly Stogner, MD Dr. Stogner has nothing to disclose.
Nabeela Nathoo, MD, PhD Dr. Nathoo has nothing to disclose.
Joon H. Uhm, MD, FRCP(C), FAAN Dr. Uhm has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Zai Lab.
Alyx B. Porter, MD, FAAN Dr. Porter has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities.
Julie E. Hammack, MD, FAAN Dr. Hammack has nothing to disclose.
Kurt A. Jaeckle, MD, FAAN Dr. Jaeckle has stock in Entegrion, Inc.
Maciej M. Mrugala, MD, PhD, MPH, FAAN Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.
Brian Crum, MD Dr. Crum has nothing to disclose.
Sean J. Pittock, MD Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc. Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman/LaRoche AG. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hofman/LaRoche. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received research support from Grifols. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Viela Bio/MedImmune/Horizon. The institution of Dr. Pittock has received research support from Alexion Pharmaceuticals. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. The institution of Dr. Pittock has received research support from NovelMed. The institution of Dr. Pittock has received research support from AstaZeneca. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care.
Carl Christopher Hook, MD Dr. Hook has nothing to disclose.
Tammam Dayyoub, MD No disclosure on file
Isabella Sutherland Ms. Sutherland has nothing to disclose.
Alissa Ashley Thomas, MD, FAAN Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roon. The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Adam Ulano, MD Dr. Ulano has nothing to disclose.
Ahmad Riad Ramadan, MD Dr. Ramadan has received publishing royalties from a publication relating to health care. Dr. Ramadan has received publishing royalties from a publication relating to health care.
Diana M. Barratt, MD, MPH, FAAN Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legally Pink, LLC.
Amina Namrouti Miss Namrouti has nothing to disclose.
Denis Babici, MD Dr. Babici has nothing to disclose.
Michael William McDermott, MD Dr. McDermott has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. McDermott has stock in Zap Surgical . Dr. McDermott has stock in Deinde Medical. The institution of Dr. McDermott has received research support from State of Florida . Dr. McDermott has received intellectual property interests from a discovery or technology relating to health care.
Kathleen Thompson, DO Dr. Thompson has nothing to disclose.
Yazmin Odia, MD, FAAN, MS Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile.
Zhi-Jian Chen, MD Dr. Chen has nothing to disclose.
Panayiotis Mitsias, MD Dr. Mitsias has nothing to disclose.
Michele Persico, MD Dr. Persico has nothing to disclose.
Jim Zhong, MD Dr. Zhong has nothing to disclose.
Hui-Kuo Shu, MD Dr. Shu has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novocure. Dr. Shu has stock in Gilead. Dr. Shu has stock in Akebia Therapeutic. The institution of Dr. Shu has received research support from Novocure.
Yuliya Snyder, MD Dr. Snyder has nothing to disclose.
Bryan Joseph Neth, MD, PhD Dr. Neth has nothing to disclose.
Ugur Sener, MD Dr. Sener has nothing to disclose.
Zafer Keser, MD Dr. Keser has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Practice Update.
Derek Johnson, MD Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix.
David Nathan Abarbanel, MD Dr. Abarbanel has nothing to disclose.
Rafid Mustafa, MD Dr. Mustafa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics.
Jonas Paludo, MD The institution of Dr. Paludo has received research support from karyopharm. The institution of Dr. Paludo has received research support from Biofourmis.
Stephen Ansell, MD,PhD Dr. Ansell has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Hematology .
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Michel Toledano, MD Dr. Toledano has nothing to disclose.
Colleen Donlin-Smith No disclosure on file
Nupur Lala, MD Dr. Lala has nothing to disclose.
Matthias Karajannis An immediate family member of Matthias Karajannis has stock in 3M. Matthias Karajannis has stock in Doximity. Matthias Karajannis has stock in Johnson & Johnson. The institution of Matthias Karajannis has received research support from Ymabs. Matthias Karajannis has received publishing royalties from a publication relating to health care.
Elena Pentsova, MD The institution of Dr. Pentsova has received research support from YmAbs Therapeutics, Inc.
Maya Srikanth Graham, MD The institution of Dr. Graham has received research support from the Matthew Larson Foundation. The institution of Dr. Graham has received research support from Hyundai Hope on Wheels. The institution of Dr. Graham has received research support from the American Cancer Society. The institution of Dr. Graham has received research support from Team Jack Foundation. The institution of Dr. Graham has received research support from the A. James and Alice B. Clark Foundation. The institution of Dr. Graham has received research support from NINDS.
Eva Pressman No disclosure on file
Neil Sielski, MD Dr. Sielski has nothing to disclose.
Christian Grommes, MD Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grommes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curis. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono.
Lauren Rhea Schaff, MD Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO. Dr. Schaff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BTG Pharmaceuticals. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. An immediate family member of Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MichieHamlett Attorneys at Law. The institution of Dr. Schaff has received research support from BTG, plc. The institution of Dr. Schaff has received research support from Merck. The institution of Dr. Schaff has received research support from DebioPharm.
Ramnath Santosh Ramanathan, MD No disclosure on file
Dhvani Raghupathy Dhvani Raghupathy has nothing to disclose.
Sneha Lingam Ms. Lingam has nothing to disclose.
Deepal Pankaj Shah-Zamora, MD Dr. Shah-Zamora has nothing to disclose.
Emily Poole Pharr, MD, FAAN Dr. Pharr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Rakhee Vaidya, MBBS Dr. Vaidya has nothing to disclose.
Keirsyn Criss No disclosure on file
Kathryn Mercer No disclosure on file
Danielle L.V. Maracaja, MD The institution of Dr. Maracaja has received research support from Beckman Coulter.
Konark Malhotra, MD Dr. Malhotra has nothing to disclose.
Sona Ohanyan, MD Dr. Ohanyan has nothing to disclose.
Shahar Shelly, MD Dr. Shelly has nothing to disclose.
Chen Buxbaum, MD Dr. Buxbaum has nothing to disclose.
Chris Hackett, MA Mr. Hackett has nothing to disclose.
Ariana Michelle Frontario, DO Dr. Frontario has nothing to disclose.
Melissa Tian No disclosure on file
Michael Edward Limia Mr. Limia has nothing to disclose.
Caroline Thomas Caroline Thomas has nothing to disclose.
Matthew Gorris, MD An immediate family member of Dr. Gorris has received personal compensation for serving as an employee of Cook Medical.
Cynthia Burns, MD Dr. Burns has nothing to disclose.
Darshil Shah, MBBS Dr. Shah has nothing to disclose.
Khushboo Verma, MBBS Dr. Verma has nothing to disclose.
Alexander Vartanov, MD Dr. Vartanov has nothing to disclose.
Matthew Zibelman, MD Dr. Zibelman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Zibelman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exelixis. Dr. Zibelman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Replimmune. The institution of Dr. Zibelman has received research support from Exelixis. The institution of Dr. Zibelman has received research support from Bristol Myers Squibb.
Jonathan Toib Mr. Toib has nothing to disclose.
David G. Wright, MD Dr. Wright has nothing to disclose.
Micah Sy, MD Dr. Sy has nothing to disclose.
Paul Wright, MD, FAAN Dr. Wright has nothing to disclose.
Faisal Abdelaziz Ibrahim, MD Dr. Ibrahim has nothing to disclose.
Janet C. Rucker, MD Dr. Rucker has nothing to disclose.
Nicolas Julian Abreu, MD The institution of Dr. Abreu has received research support from Adult Polyglucosan Body Disease Research Foundation. The institution of Dr. Abreu has received research support from Sanofi Genzyme. The institution of Dr. Abreu has received research support from Takeda. The institution of Dr. Abreu has received research support from Sangamo.
John-Ross Rizzo, 10770 No disclosure on file
Todd Hudson Todd Hudson has received stock or an ownership interest from Tactile Navigation Tools, LLC. Todd Hudson has received publishing royalties from a publication relating to health care.
Naim I. Haddad, MD, FAAN Dr. Haddad has nothing to disclose.
Kemar Earl Green, DO Dr. Green has nothing to disclose.
Arens Taga, MD Dr. Taga has nothing to disclose.
Mefkure Eraksoy, MD Dr. Eraksoy has nothing to disclose.
Haochen Wei Haochen Wei has nothing to disclose.
Preetham Bachina Mr. Bachina has nothing to disclose.
Peter Hopkins Kazanzides, PhD Dr. Kazanzides has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medivis.
Tzu-Ching Wu, MD Dr. Wu has nothing to disclose.
Kyra O'Brien, MD Dr. O'Brien has nothing to disclose.
Jason H T Karlawish, MD No disclosure on file
Kristin Harkins, Other Ms. Harkins has nothing to disclose.
MaryAnne Peifer, MD Dr. Peifer has nothing to disclose.
Cameron Coykendall Mr. Coykendall has nothing to disclose.
Melanie Kleid, Other Ms. Kleid has nothing to disclose.
Robert E. Burke, MD The institution of Dr. Burke has received research support from National Institutes on Aging. The institution of Dr. Burke has received research support from Agency for Health Research and Quality. The institution of Dr. Burke has received research support from VA Health Services Research and Development.
Judy A. Shea, PhD Prof. Shea has nothing to disclose.
Steffan Soosman No disclosure on file
Daniel Paul Ashley, MPA Mr. Ashley has nothing to disclose.
Christian Gericke, MD PhD MPH MSc FAAN Dr. Gericke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Ltd. Dr. Gericke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medicines Australia. Dr. Gericke has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Australian Hospital and Healthcare Association. Dr. Gericke has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Australian Government Agencies.
Meredith Nicole Braskie No disclosure on file
Vani Kumar Ms. Kumar has nothing to disclose.
Elizabeth Chernyak, MD Dr. Chernyak has received research support from Maimonides Research and Development Foundation .
Nisma Hussein, Other Miss Hussein has nothing to disclose.
Lon Yin Chan, MD Dr. Chan has nothing to disclose.
Eymen Pinar No disclosure on file
Erkan Akkus No disclosure on file
Tugce Dilek No disclosure on file
Yilmaz Zindar No disclosure on file
Aysel Guzeler No disclosure on file
Huseyin Kilic No disclosure on file
Ömer Faruk Beser No disclosure on file
Fügen Cullu Cokugras No disclosure on file
Larry B. Goldstein, MD, FAAN, FAHA The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from CDC. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Marcondes C. Franca, Jr., MD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA.
Irene Sintini, PhD Dr. Sintini has nothing to disclose.
Calvin William Howard, MD Dr. Howard has received intellectual property interests from a discovery or technology relating to health care. Dr. Howard has a non-compensated relationship as a Founder with KiTH Solutions that is relevant to AAN interests or activities.
Ibrahim Serag, MBBS Dr. Serag has nothing to disclose.
Cori Polonski, MD Dr. Polonski has nothing to disclose.
Alma Ghirelli Ms. Ghirelli has nothing to disclose.
Anas Idris, MD Dr. Idris has nothing to disclose.
Babak Boroojerdi, MD Dr. Boroojerdi has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boroojerdi has stock in UCb Biosciences.
Marc Morris, MD Dr. Morris has received personal compensation for serving as an employee of Avidity Biosciences Inc.. Dr. Morris has stock in Avidity Biosciences, Inc..
Nicolas Prudon Mr. Prudon has nothing to disclose.
Marilyn Lepleux Miss Lepleux has nothing to disclose.
Loanne Milvoy Mrs. Milvoy has received personal compensation for serving as an employee of Treefrog therapeutics.
Helene Wurtz Mrs. Wurtz has received personal compensation for serving as an employee of Treefrog Therapeutics.
Thibault Dufourd, PhD Dr. Dufourd has nothing to disclose.
Maxime Feyeux Mr. Feyeux has stock in Treefrog Therapeutics. Mr. Feyeux has received intellectual property interests from a discovery or technology relating to health care.
Erwan Bezard, PhD Dr. BEZARD has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Motac. Dr. BEZARD has stock in Motac. Dr. BEZARD has stock in Treefrog.
Lucia Cordero Espinoza Mrs. Cordero Espinoza has nothing to disclose.
Jens Schroeder, MD,PhD Dr. Schroeder has received personal compensation for serving as an employee of TreeFrog . Dr. Schroeder has stock in Bayer Leverkusen . Dr. Schroeder has stock in Coagulant Therapeutics . Dr. Schroeder has received intellectual property interests from a discovery or technology relating to health care. Dr. Schroeder has received intellectual property interests from a discovery or technology relating to health care.
Basile Valéry Pierre Gurchenkov, PhD Dr. Gurchenkov has received personal compensation for serving as an employee of TreeFrog Therapeutics.
Agathe Jonckeau Dr. Jonckeau has nothing to disclose.
Michaël Lanero Fidalgo, Other Mr. LANERO FIDALGO has nothing to disclose.
Guillaume Dabee Mr. Dabee has nothing to disclose.
Kevin Alessandri Dr. Alessandri has received personal compensation for serving as an employee of treefrog therapeutics. Dr. Alessandri has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for treefrog therapeutics. Dr. Alessandri has received intellectual property interests from a discovery or technology relating to health care.
Justine Pletenka Miss Pletenka has nothing to disclose.
Pauline Morand Mrs. Morand has nothing to disclose.
Léa Poinçot Miss Poinçot has nothing to disclose.
Elisa Luquet, MD Miss Luquet has nothing to disclose.
Fabien Moncaubeig Mr. TREEFROG has received personal compensation for serving as an employee of Treefrog Therapeutics. Mr. TREEFROG has stock in Treefrog Therapeutics.
Maëlle De Marco Miss De Marco has received personal compensation for serving as an employee of TreeFrog Therapeutics.
Myriam Abarkan, PhD Mrs. Abarkan has received personal compensation for serving as an employee of Treefrog Therapeutics.
Emilie Faggiani, PhD Dr. Faggiani has nothing to disclose.
Chloe Morel Mrs. Morel has nothing to disclose.
Verena Ramirez Campos, MD Dr. Ramirez Campos has received personal compensation for serving as an employee of teva.
Mario Ortega, PhD Dr. Ortega has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Juan Ignacio Kenny, MD Dr. Kenny has nothing to disclose.
Karen Carr, PhD Dr. Carr has nothing to disclose.
Rita Singh, PharmD Dr. Singh has received personal compensation for serving as an employee of AbbVie. Dr. Singh has stock in AbbVie.
Sujal Manohar Ms. Manohar has nothing to disclose.
Kristen Staggers, Other Ms. Staggers has nothing to disclose.
Ellen Jean Fremion, MD Dr. Fremion has nothing to disclose.
Heidi Castillo, MD Dr. Castillo has nothing to disclose.
Jonathan Castillo No disclosure on file
Xiaofan Huang Ms. Huang has nothing to disclose.
Aditi Sharma, MBBS Dr. Sharma has nothing to disclose.
Satish C. Rao, MD,MS Dr. Rao has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rao has stock in Takeda Pharmaceuticals.
Ana Maria Roman, MD Dr. Roman has nothing to disclose.
Justine Ker, MD Dr. Ker has nothing to disclose.
Ankur Patel, MD No disclosure on file